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Abstract:
Nontuberculosis Mycobacteria (NTM) are now considered a major source of opportunistic
infection in immunocompromised patients. Reliable and rapid identification of NTM species
is of the upmost importance for patient treatment regimes. Firstly, this study looked at the
epidemiological trends of a small number of NTM isolates (n=50) from a large teaching
hospital in Southern Ireland Cork University Hospital (C.U.H.). We found that 85% of
clinical isolates were sampled from the respiratory tract, which is not unusual as the majority
of samples analysed in the hospital lab originated from sputum samples. Also, the majority of
patients were 59 years of age or older (62%). 42% of isolates donated were found to be MAC
{Mycobacterium avium complex), which is regularly the most commonly extracted NTM
strain in clinical environments. In addition to the Cork study, 50 MAC isolates were donated
by St James' Hospital Dublin. No patient information was given with these isolates; although
from the incidence data provided it was clear that MAC isolates were in general the most
frequently identified NTM, with 86 / 259 isolates recovered over 7 years.
We identified the combined 100 NTM to a species and sub-species level, using several
molecular methods. These results were then compared to biochemical analysis and
identification methods carried-out by both hospitals. The first molecular method employed
was 16S rRNA gene typing, which was compared to the genomic databases (BLAST and
RIDOM). Both data bases gave identical species results for all 100 isolates, indicating the
utility of these on-line systems. After 16S typing, 3 of the Cork isolates (6%) were shown to
be different to the species typed, which was assigned following the biochemical analysis at
C.U.H. There was 100% agreement between the species identification obtained from St
James' Hospital laboratories and this study, although some of the MAC isolates were re
classified by the hospital after we received them. 16S typing on our part confirmed the
validity of the re-classification.
One drawback of 16S typing is the poor discrimination at the sub-species level between
closely related mycobacteria such as MAC. Therefore it was necessary to apply additional
molecular profiling techniques for the identification of NTM at a sub-species level. IS
(Insertion Sequence) elements (IS 1900, IS901, IS1311 and IS 1245) and sequevar analysis
were used to identify 66 MAC isolates to a sub-species level. IS elements rapidly identify
mycobacteria without the need for sequencing, and virulence potential can also be established
using this system. It was determined using IS profiling that 94% of MAC isolates from Cork
vi

and Dublin were virulent M avium subsp hominissuis. The remaining 6%, were positive for
1S1311, and were negative for all other IS elements (IS 1245, IS900 and IS901). This result in
conjunction with 16S typing results identified these isolates as M. intracellulare.
The final molecular tool used in this study of 66 clinical MAC isolates was hsp65
sequevar profiling to confirm the sub-species identity. After PCR analysis and sequencing,
each MAC isolate was aligned with the MAA104 reference genome to quickly identify
strategic SNPs and assign a sequevar code. In total, 68% of the MAC isolates were
represented by code 1, while 23% were identified as code 2. 3% were confirmed as code 3.
All 3 sequevar codes represent M. avium subsp hominissuis which correlated with the IS
profiling. Finally, 4 isolates (6%) of the cohort which were originally identified as MAC by
St James' were re-classified as M intracellulare code 10 following sequevar analyses and
16S typing.
In tandem with this clinical analysis, an environmental study was also undertaken to establish
the diversity of NTM from a variety of water sources. Two decontamination methods were
chosen for this study (CPC and NaOH). It was necessary to optimise both of these methods
prior to screening the environmental samples. In total 70 water samples were collected from
the greater Cork region and processed using both decontamination procedures. From the
analysis 5 isolates (7%) were positive for NTM and identified as M alvei, M. tokaiense,
M.gordonae and M. murale. Only one of these isolates {M.gordonae) is commonly isolated
from clinical environments as an opportunistic pathogen in immunocompromised individuals.
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Chapter I
Literature Review

l.l INTRODUCTION AND GERERAL OVERVIEW TO MYCOBACTERIA
LLl. History
In recent years many new mycobacteria have been described due to recent advances
in identification and taxonomyThere are now thought to be 142 species of mycobacteria
present in the world to-date^'^. Many of these species can be broken down into different
groups, which will be discussed further on. The most famous of these is Mycobacterium
tuberculosis, the bacterium known to cause tuberculosis (TB) in humans. This is a
progressive disease that usually attacks the lungs but can also affect the central nervous
system, lymphatic system, circulatory system, genitourinary system and gastrointestinal
system, as well as bones, joints, and even the skin*^.
Mycobacterium tuberculosis has been present in the human population since
antiquity. Fragments of the spinal column from Egyptian mummies from 3,400BC show
definite pathological signs of tubercular decay^^. The word consumption (the original term
for this disease), first appears in Greek literature around 460BC and was identified as the
most widespread disease of the time.
By the mid 17th Century one in 5 deaths in London, as recorded in the bill of
mortality, were due to TB. The disease soon became an epidemic in Britain, with large cities
in the USA and central Europe becoming engulfed by the "white plague". Throughout the
centuries the pathological and physical descriptions of consumption were beginning to be
described by various doctors of the time. In 1720 an English physician, Benjamin Marten,
first conjured in his publication" A new theory of consumption" that TB could be spread from
person-person

By the turn of the 19th Century the estimate of the worldwide TB death rate

stood at 50 million per year, which led to the fear that by the end of the 19th Century
European civilisation might be destroyed.
M. tuberculosis is still among the most successful human pathogens worldwide, and
is responsible for extensive morbidity and mortality, with approximately 2 million deaths
each year. Many of the deaths occur in underdeveloped countries where access to vaccines
and modem medicine is limited.

Despite its notoriety in modern times, M.tuberculosis was not the first species of
mycobacteria to be discovered, in 1873 Armauer Hansen unveiled Mycobacterium leprae, the
bacterium known to cause leprosy. This is considered to be a progressive disease that causes
permanent damage to the skin, nerves, limbs and eyes. Leprosy, one of the world's oldest
diseases (considered to be at least 4,000 years old), was well recognised in the cultures of
ancient China, Egypt and India^^. Leprosy is considered to be a progressive disease that
causes permanent damage to the skin, nerves, limbs and eyes. It was the Middle Ages before
leprosaria, or leper hospitals sprang up; Matthew Paris, a Benedictine Monk, estimated that
in the early thirteenth century there were 19,000 across Europe'^.
In the past 20 years, 15 million people worldwide have been cured of leprosy. Despite
this, the prevalence of leprosy at the beginning of 2008 stood at 212,802 cases^^. Although
the forced quarantine or segregation of patients is unnecessary in many places where
adequate treatments are available, many leper colonies still remain around the world in places
such as India where over 1000 colonies still exist.
In terms of therapy and prevention, the first major breakthrough was in 1921. This involved
the development of a vaccine by French bacteriologist Calmette together with Guerin, where
specific culture media was used to lower the virulence of the bovine TB bacterium creating
the basis for the BCG vaccine, which is still in widespread use today. Effective treatment for
leprosy and TB was greatly assisted by the introduction of Multidrug therapy (MDT) in the
early 1980's, so that the diseases could be diagnosed and treated effectively within the
community. MDT consists of rifampicin, dapsone and clofazimine taken over 12 months.
Nontuberculous mycobacteria (NTM), another clinically important group, were first
recognised in the 1950s when the prevalence of tuberculosis fell . This group is made up of
approximately 130 species, and causes disease such as cervical lymphadenitis in children^*",
or Buruli ulcer, a severe skin condition. NTM have also been associated with Crohn's disease
in humans . Once the discovery of these new strains occurred, it was necessary to set up a
new classification system. This led to the introduction of Runyon’s classification in the mid
fifties, which involved the NTM being grouped into 4 categories as outlined below (Table
1.1).

Using this system, NTM are divided by growth rates and pigment production. Groups
I to III are slow-growing NTM, and group IV are fast growers. The slow-growing NTM

(SGM), which take longer than 7 days to grow, are subdivided into group I photochromogens
(pigment producers in the presence of light), group II scotochromogen (pigment producers in
the absence of light), and group III nonchromogens. Although replaced by more modem
genetic techniques, this classification system provides physicians with a clinically relevant.
presumptive speciation mechanism 54
Runyon’s Classification of Nontuberculous Mycobacteria
Runyon’s
Class

Description

Growth

Pigment Production

I

Photochromogens

Slow
growing

II

Scotochromogens

Slow
growing

III

Nonchromogens

Slow
growing

None

M. xenopi

IV

Rapid Growers
(form colonies in
under 7 days)

Rapid
growing

None

M. chelonae

Yellow-orange pigment
production when exposed to
light
Yellow-orange pigment
production with or without
light

Species e.g.
M. kansasii

M. gordonae

Table 1.1. Illustrating Runyon’s Classification of NTM 104

1.1.2 Microbial characteristics and physical properties of mycobacteria
The genera Mycobacterium has been grouped into the family Mycobacteriaceae
within the order actinomycetales. They are defined by their acid-fast properties, and unique
cell wall and their high genomic C+ G content (55-70%)^°’^^^.
Mycobacteria are non-motile, gram-positive bacilli with a common cell wall that is thicker
than other bacteria. This is due to the large amount of lipid present, which makes up
approximately 40% of the total dry cell weight . The mycobacterial cell wall core consists of
two layers; the highly impermeable outer layer is composed of mycolic acids (carboncontaining lipids), while the inner layer consists of peptidoglycan. These two layers are
covalently tethered via the connecting polysaccharide arabinogalactan which is illustrated in
Figure 1.1 79

(LAM)

Superficial lipids
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Figure 1.1 Complex cell wall structure of mycobacteria^^
Due to the cell being rich in mycolic acids or mycolates, the cell is given a waxy
appearance. The mycolic acids in the cell wall lead to all species being characteristically
stained as acid-fast bacilli (AFB), which gives them the appearance of slender curved rods.
The most common stain used in the identification of the bacteria is the Ziehl-Neelsen stain,
due to its ability to stain the lipid-rich cell wall of the bacteria.
In clinical specimens there can be slight variation in shape and size depending on the
species being examined. Species variations are characterized by variation in sugar
substitutions in the glycolipids or peptidoglycolipids. This important property allows
differential staining in contaminated clinical specimens such as sputum. As outlined earlier,
mycobacteria can also produce pigments. Some produce carotenoid pigments without light,
others require photo-activation for pigment production.
1.1.3 Cultivation of Mycobacteria
Mycobacteria are extremely fastidious to cultivate, with some isolates taking several
months to grow^^. They generally require selective media to grow, such as the widely-used

Lowenstein-Jensen (egg-based) or standard lab media such as Middlebrook 7H10 and 7H11
generally with added OADC (Oleate-albumin-dextrose-catalase) supplement.
Egg-based media were introduced by Dorset in 1903^^’

and are the most

commonly used media for the isolation of mycobacteria from clinical specimens. Most eggbased media are composed of whole eggs, organic and inorganic salts, asparagine, and
glycerol as a carbon source. In order to observe the buff-coloured colonies of mycobacteria, it
is usual practice to add a coloured dye to the medium before coagulation. The most widelyused dye is malachite green, which has an added advantage of being slightly inhibitory to
small numbers of contaminating organisms.
The most widely used agar-based media are those developed by Middlebrook. These
are the "7H" media, and have been developed through a series of changing formulae with
increasing numbers. Each slight alteration to the constituents has led to a change in medium
number. Middlebrook 7H10 and 7H11 are the most useful agar-based media, and only differ
by the addition of casein hydrolysate to 7H11, which improves the growth of some fastidious
strains of mycobacteria.
Along with OADC supplement, some strains of NTM bacteria require special
supplementation for recovery on culture. For example, M haemophilum requires a media
containing iron compounds such as ferric ammonium citrate or haemoglobin, and
Mycobacterium avium paratuberculosis (MAP) also requires mycobactin for optimal growth.
All cultures of mycobacteria should include both solid and liquid media for the
detection and enhancement of growth. Cultures in broth generally produce a higher yield of
mycobacteria, and produce more rapid results. The advantage of solid media over broth is
that it allows for observation of colony morphology, growth rates, recognition of mixed
infection and quantification of infecting microorganisms'^^.
Optimum incubation of NTM depends on the species being isolated. With unknown
samples, the optimum temperature is between 28°C and 37°C. Slow-growing mycobacteria
(SGM) generally tend to favour 35°C- 37°C during primary isolation, mainly due to the long
incubation period. Certain strains such as M. haemophilum tend to grow better between 28°30°C, while some strains of M. chelonae require temperatures between 28°C-33°C'^\

When processing clinical specimens for cultivation of NTM, generally a
decontamination procedure needs to be performed on all non-sterile samples, before
inoculation into media. This step is carried out because faster-growing bacteria may be
present in contaminated samples. It is necessary to ensure that the decontamination step is not
harsh enough to kill the mycobacteria in the sample, but will eliminate faster growing cells.
Traditionally, decontamination may be carried out using N-acetyl-L-cysteine-sodium
hydroxide (NaCl-NaOH) in conjunction with 5% oxalic acid, or alternatively 0.001%
Cetylpyridinium chloride monohydrate (CPC) '. Other studies have used combinations of
malachite green (2%), cycloheximide, and NaOH^ or NaOH and sulfuric acid*^^.
1.1.4 Transmission ofMycobacteria
The modes of transmission have not been defined in NTM, although person-person
transmission is not thought to occur'^^ Disease in humans is suspected to be acquired from
environmental exposure, although the specific source of infection usually cannot be
identified, even though transmission through water or soil is thought possible^^’Mainly,
infected individuals are either immunocompromised or undergoing immuno-suppressive
therapy.
Transmission can occur through an aerosol-based route. Infection may occur when a
susceptible host inhales aerosolised droplets containing mycobacteria. Mycobacterium avium
complex (MAC), which is the second most commonly isolated group of mycobacteria outside
of TB, has been isolated from a variety of sources, including the environment and hospital
water distribution system, where it is thought that aerosolised water serves as the main source
of pulmonary infection, especially from showers and hot-tubs ’ ’

’ ’ .

Many mycobacteria are undoubtedly inhaled, and this is the predominant transmission
route for most pathogenic species, either lodging in the nose, or passing through the trachea
and bronchi to the alveoli. Clumps of two or three bacilli may reach the alveolar passages
where they are taken up by alveolar macrophages and pathogenesis proceeds.
Mycobacteria are not thought capable of invading the intact skin, but are well known
to enter through minor abrasions, being rapidly phagocytosed by polymorphs and
macrophages. Both M. chelonae and M. ulcerans infection may start from such sites^^^.

Recently there has been an increase in nosocomial infections. It is thought nosocomial
infections may be transmitted by drinking water, bathing, showering or contact with medical
equipment which was recently cleaned with contaminated tap water’^^. This is mainly due to
the mycobacterial cell's ability to survive chlorination in hospital water systems, and their
■^o

ability to forni biofilms .
1.1.5 Introduction to pathogenesis ofNTM
As already stated, TB is considered one of the most pathogenic diseases in the modern
world, being responsible for 2 million deaths a year^^’’ *’

It is also estimated that a third to a

half of the world's population is infected with the disease^^, which may remain latent in a
healthy host, thereby avoiding activation for many years.
NTM on the other hand are generally considered opportunistic human pathogens,
whose main habitat is the environment . In recent years many species ofNTM have been
recovered from environmental sources such as water (drinking and natural), soil, aerosols and
biofilms 33
Compared to TB and leprosy, NTM are considered to have lower virulence and have
not shown any evidence of human-to-human transmission^^’

Not all NTM are pathogenic.

Initially it was thought that only SGM could cause infection. However, with the identification
of more ROM each year it has now been proven that they too are capable of causing disease
in immunocompromised hosts^^^’^^’^^.
When pathogenic NTM enter the body they can be successful at evading the body
defences. This is mainly due to their waxy coats, which enable them to survive the severe pH
of the stomach acid. Once at their preferred site of infection, which can include lungs, tissue
or skin, these bacteria allow themselves to be phagocytosed by macrophages, which makes
them impermeable to destruction, allowing them to multiply'^’. Consequently, the host
responds and interleukin (IL)-12 is synthesised, which in turn regulates interferon (IFN)
This activates neutrophils and macrophages to kill intercellular pathogens, including
mycobacteria, leading to extensive inflammation at the site of infection. Ultimately therefore,
disseminated NTM disease is a definitive manifestation of immunological irregularities,
caused by defects in the above IFN~ y/ IL-I2 pathways'^^’

Healthy individuals are usually able to control the disease, whereas
immunocompromised individuals can develop chronic infections. Resistance may be
mediated by lymphocytes, although the specific type required to control mycobacterial
infection has not been fonually defined. However, CD4, CDS, and some non-classical
lymphocytes have been shown to react to mycobacterial antigens and also to expand in
numbers within the infected area*^^. Depending on the health status and genetic deposition of
the individual being infected, the host’s immune system can respond differently. For
example, in patients infected with HIV when the C4+ lymphocyte counts fall below 100,
'>/r

NTM infections may occur

. Also, in the patient group who aren't infected with HIV,

genetic syndromes of disseminated NTM infection have been associated with specific
mutations in interferon (IFN)-y and interleukin (1L)-12 syntheses and response pathways'"^.

1.1.6 Vaccination
The original vaccination of TB and leprosy developed by Calmette and Guerin in 1921 is still
in regular use today, with 100 million children receiving the vaccine each year^^. The
vaccination known as Bacille Calmette-Guerin (BCG) consists of an intradermal injection of
a small number of living tubercle bacilli rendered of low virulence by the process of
attenuation. When it is effective it provides long-lasting protection from leprosy and
tuberculosis of up to 80% following a single dose. BCG is still the only current tuberculosis
(TB) vaccine^^.
Prophylactic vaccination with BCG is successful when the individual being
vaccinated has an immune system primed to make a Thl response which can be maximised,
resulting in rapid recognition of invading common mycobacterial antigens. When Th2
mechanisms predominate, the requirement is for preventative immunotherapy, and for this
BCG is inadequate*
As previously mentioned, the BCG vaccine is still the main preventative against the spread of
mycobacterial infection. Despite its widespread international use, however, it has not been
effective in controlling the global TB epidemic; therefore it is necessary to develop new
vaccines to help control the spread of mycobacterial infections. It is thought that the BGC
vaccine could be replaced with a recombinant BCG (rBCG) or attenuated Mth strain. These
approaches are being explored to replace the standard BCG with an improved priming
vaccine^. Research also continues into the development of novel vaccines, such as Okadas et

al's DNA vaccine expressing mycobacterial heat shock protein 65 (hsp65) and interleukin12 (IL-12) delivered by the hemagglutinating virus of Japan (HVJ)-liposome (hsp65 + IL12/HVJ).
1.1.7 Antimicrobial Resistance ofMycobacteria
-Treatment
Treatment regimens for diseases caused by NTM are still largely undefined, and the outcome
remains disappointing despite upgrading in laboratory diagnosis and the availability of new
antimicrobials. Treatment success is impaired by the long duration of regimes, side-effects,
and drug interactions, which contribute to patient non-compliance and unsuccessful
treatments 49
Treatment is dependent on the area of infection and the type of subspecies identified.
Most clinical isolates are resistant m vitro to a wide range of drugs including
antimycobacterial agents; therefore a large number of antibiotics administered in
combinations are required to fight these infections^\ Some of the drugs used to fight MAC
infections, as mentioned briefly earlier, include clarithromycin, azithromycin, ethambutol and
rifampicin.
M. kansasii can be resistant to several antibiotics, although their susceptibility to
antimycobacterial drugs varies in vitro. The current recommendation for treatment of
pulmonary disease includes a combination of ethambutol, rifampicin and isoniazid.
Treatment is generally recommended to be carried-out over an 18-month period, and
monitoring of the patient should continue for a further 12 months to ensure a relapse does not
occur 138
M abscessus is more resistant to many antibiotics both in vivo and in vitro.
Consequently it is necessary to carry-out testing of clinically significant isolates. However
they are generally susceptible to amikacin, cefoxin (pulmonary infections) clarithromycin and
azithromycin (skin and soft tissue infections) 28

10

-Resistance
Antibiotic resistance in NTM can occur by a variety of mechanisms. These
mechanisms are typically divided into five main categories (adapted from

).

1. Decreased uptake or impermeability.
2. Increased efflux.
3. Enzymatic inactivation.
4. Modification of the antibiotic target.
5. Reduced pro-drug-activating enzyme activity.
These mechanisms of resistance may be a result of intrinsic (natural) resistance, or acquired
means. Intrinsic or natural resistance refers to resistance that is not caused by any genetic
alteration, while acquired resistance is due to a mutation or transfer of genetic material
Mycobacteria are naturally resistant to all of the antibiotics that affect the cell wall,
including penicillin and cephalosporin. This is mainly due to the high lipid content of the
mycobacterial cell wall. Resistance can rapidly occur subsequent to the use of a single
antimicrobial to which the bacteria was originally susceptible, due to mutations in the
chromosomal gene encoding the target of the antibiotic"*^.
TB has several means of intrinsic resistance. For example, TB has a very hydrophobic
cell surface, which provides a permeability barrier for some antibiotics. Also TB possesses
some enzymes such as beta-lactamase necessary to inactivate penicillin. Aside from natural
resistance, TB has acquired resistance mechanisms to anti-tuberculosis drugs by spontaneous
mutations in chromosomal genes such as embCAB gene cluster*'^.
Each NTM species has the ability to develop resistance to many antibiotics; for
example, MAC is resistant to many of the first-line anti-tubercular agents , such as isoniazid,
rifampin, ethambutol, pyrazinamide and streptomycin. In all clinical cases it is wise to rely on
susceptibility testing. This can be used to check for primary drug resistance and acquired
drug resistance for a species of mycobacteria, and will guide the choice of further treatment
with different drugs'*^.

11

1.2. GROUPS OF MYCOBACTERIA
1.2.1. Introduction to groups ofNTM
Despite the potentially useful benefits of the Runyon classification system, the
discovery of more species of mycobacteria required a more detailed classification system.
With 142 species of mycobacteria present in the environment it is necessary that they be
divided into groups for the purpose of correct and rapid diagnosis and treatment. The most
commonly recognised group is the Mycobacterium tuberculosis complex (MTBC). This
group causes tuberculosis in humans and animals. It consists of M. tuberculosis, M. bovis, M.
africanum, M. microti and M. canelti . The second group consists solely of Mycobacteria
leprae, the bacterium that causes leprosy in humans.
All other mycobacterial species fall into a group known as NTM. They are all the
other mycobacteria, which can cause pulmonary disease resembling tuberculosis,
lymphadenitis, skin disease, or disseminated disease. There are approximately 130 species in
this category. Other names for this group include atypical mycobacteria, environmental
mycobacteria and mycobacteria other than tuberculosis (MOTT) ’ .
Since this category contains such a large number of species it can further be divided
into two sub categories called rapidly growing mycobacteria (ROM) and slow growing
mycobacteria (SGM). In these two categories the NTM can either be considered saprophytes
(generally non-pathogenic), or opportunistic pathogens that cause infection in the host.
Approximately 50 of the NTM species are currently considered agents of disease. Most of
these originate from the SGM group, with only a few being associated with RGM^^"^. Figure
1.2 provides a breakdown of a broad classification system for mycobacteria.

12

e.g. M tuberculosis,
M. hovis.
_______________________

RGM

j

SGMs

I

;
Pathogenic

e.g. M abscessus

{

e.g. M. tokaiense

e.g. MAC

e.g. M avium
sub avium.

Figure 1.2 Broad classification scheme for the main groups of Mycobacteria
RGM are species that require 7 days or fewer to form colonies on solid media93 .
Currently there are approximately 60 species of RGM in the environment ; most of them are
saprophytes common in all ecosystems . With the identification of new species, and the
development of more accurate identification methods, RGM have been associated with
wound infections, abscess formation and chronic lung infection in immunocompromised
patients^^’

Two of the most common RGM include M. chelonae and M. abscessus.
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SGM are generally species that form colonies after 7 days of incubation

but can

take weeks or even months to grow on selective media. There are approximately 70 SGM
species and unlike RGM most of the SGM tend to be opportunistic pathogens. One of the
most clinically significant species of SGM is the MAC {Mycobacterium avium complex),
which is the most common cause of pulmonary illness outside of M. tuberculosis^^. A
phylogentic tree is a useful tool in identifying the relationship of the mycobacteria species as
illustrated in Figures (1.3) and (1.4) for both RGM and SGM taken from Tortloi's

review

on mycobacteria.
It should be noted that from this point on, that all topics will relate only to NTM from
clinical and environmental sources. TB and leprosy will no longer be discussed and referred
to in the coming sections.
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Figure 1.3 The 16S rRNA gene-based phylogentic tree of rapid growers

{Mycobacterium tuberculosis out group SGM used for comparison)^^^’".

Key: Species in yellow were encountered in this study:
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0.00

Figure 1.4 16S rRNA gene-based phylogentic tree of slow growers characterised by a
long helix 18, (with M. fortuitum out group RGM used as comparison)^^^’^

Key: Species in yellow were encountered in this study :
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1.2.2 Clinically Significant NTM
As mentioned previously, NTM are common in all natural ecosystems and many are
now being associated with clinical infections. They have been reported as opportunistic
pathogens causing pulmonary infections, cutaneous infections, osteomyelitis and catheter
related infections^*. The clinical importance of several mycobacterial species has increased
especially since the human immunodeficiency virus (HIV) pandemic
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When it comes to the identification of clinical mycobacteria, the rapid and accurate
identification of NTM at a species level is very important for patient treatment*^^. This is
because the method of antimicrobial treatment is very different depending on the NTM
species isolated'*^.
Table (1.2) which contains data obtained from the American Thoracic Society study
on Diagnosis Treatments and Prevention of Nontuberculous Mycobacterial Diseases shows
the most common clinical mycobacteria, where they cause infection, and their drug
susceptibility. Out of all the common clinical mycobacteria three have recently been isolated
more frequently than the rest: they include MAC, M. ahscessus and M. kansasii^'^.

• M. avium complex (MAC)
The most common NTM infections are caused by the MAC as they are the most
frequently isolated species*"*^. These slow growing, non-pigmented, acid fast bacilli are
considered a major pathogen in both animals and humans . Infections caused by MAC are
increasing annually in many countries. Like all virulent mycobacteria, they are opportunistic
pathogens that mainly cause disseminated disease in human immunodeficiency virus (HIV)
patients and other immunocompromised individuals^.
- MAC subspecies

Mycobacterium avium and Mycobacterium intracellulare are collectively known as
the MAC and are slow-growing acid fast bacilli’"*^. For genotypic, phenotypic, and historical
reasons, multiple subspecies of M. avium are recognised; including:-
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1 1 u 1 11 V M

Common NTM

Infections sites

Drug freatments

M. avium complex‘s

Pulmonary,

Clarithromycin. Rifamycin

Lung tissue

M kansasif

Pulmonary

Isoniazid, rifampicin and
ethambutol

Lung tissue

M. abscessus^

Skin, bone soft
tissue, pulmonary

Tobramycin, clarithromycin,
linezolid, imipenem

Abscess
formation,
lung tissue

M. chelonae^

Skin, bone soft
tissue, pulmonary

Clarithromycin, linezolid,
amikican, doxycycline

Skin lesions

M. fortutiurrf

Skin, bone soft
tissue Pulmonary,

Amikacin, ciprofloxacin,
ofloxcin

M. genavense^

Skin, bone, soft
tissue

MDT, amikacin, rifamycin,
streptomycin

M. gordonae^

Mycobacterial
contaminant

Clarithromycin, linezolid

Lung tissue.

M. haemophilum^

Soft tissue,
extremities

Clarithromycin, rifampin,
rifabutin, ciprofloxacin

Skin lesions,
lymph nodes,
joint fluid

M malmoenese^

Pulmonary, lymph
node diseases

Kanamycin

Lung tissue,
lymph node

M scrofulaceum^

Lymphadenitis
pulmonary, skin
infections

Requires susceptibility testing
before treatment can be
determined

Lung tissue,
skin lesions

M. simiae^

Pulmonary

Linezolid, sulfamethoxazole

Lung tissue

M szulgaf

Pulmonary

Rifampin, pyrazinamide

Lung tissue.

M. terrae complex‘s

Tenosynovitis,
Pulmonary

Linezolid, ciprofloxacin,
sulfonamides

Soft tissue.
Lung tissue

M ulcerans^

Skin, soft tissue

Clarithromycin, rifampin

Hand lesions

M. xenopf

Pulmonary

Rifampin, rifabutin, ethambutol.

Lung tissue.

Isolation

Lung tissue,
orbital
implants
Blood
culture, bone
marrow.
liver.

Table 1.2 Diagnosis treatments and prevention of Nontuberculous Mycobacterial
diseases^^’

“^Slow growing mycobacteria
Rapidly growing mycobacteria
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1. Mycobacterium avium subsp avium 70
2. Mycobacterium avium subsp. paratuberculosis (MAP)
3. Mycobacterium, avium subsp. hominissuis 70
4. Mycobacterium avium subsp. silvaticum 70 .
All four M. avium subspecies and M intracellulare possess a high degree of genetic
similarity, but are capable of infecting a diverse range of host species.
-Mycobacterium avium subsp. avium is the causative agent of avian TB and
occasional infections in other animals. It is also found as a disseminated pathogen in
immunocompromised humans*^\
-MAP is one of the slowest-growing mycobacterial species. Isolation from faecal
cattle specimens can take several months or years. MAP is the causative agent of Johne's
disease in ruminant livestock and wildlife

. It has been suggested that MAP may be

involved in Crohn’s disease in humans, but evidence for a link remains controversial'^^’’
-M. avium subsp. hominissuis has been associated with tuberculosis like infections in
pigs, and is an established pathogen in the environment. It has also been associated with
pulmonary infections in humans'^'’.
-M. avium subsp. silvaticum can be found in patients with Crohn's disease, but can
also be found in patients with ulcerative colitis or inflammatory bowel disease. Among
animals it is a known pathogen, causing tuberculosis in birds and enteritis in calves
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-Mycobacterium intracellulare has recently been considered as a tentative member of
the MAC although it more commonly exists within the MAI {Mycobacterium avium
intracellulare) group due to the inter-relationship of M. avium and M. intracellulare.
Consequently it is an important contributor to MAC associated pulmonary infections in
immunocompromised patients. It is also known to have a distinct environmental niche, as it is
found to be more prevalent in biofilms 121
- Sites of MAC infections
Infections caused by MAC are mainly pulmonary, with two commonly-recognised
clinical patterns. The traditional recognised presentation of MAC lung disease has been
19

apical fibrocavitary lung disease. It usually occurs in males in their late 40s who have a
history of cigarette smoking and excessive alcohol use. If untreated, it can result in extensive
cavitary lung destruction and respiratory failure. MAC lung diseases may also be present with
nodular and interstitial nodular infiltrate frequently involving the right or middle lobe. It
usually affects postmenopausal women. There have been recent studies to suggest that no
underlying illness is required for these women to become infected with this type of MAC
disease .This type of infection may sometimes be referred to as “Lady Windermere
Syndrome".
• M. kansasii
This is a slow-growing, photochromogenic mycobacterial pathogen, which is the third
most common mycobacterial species, most frequently responsible for pulmonary disease in
immunocompromised individuals^^. M kansasii lung disease closely resembles the clinical
course of MTB. Symptoms are generally identical to those associated with pulmonary TB.,
and this pathogen is commonly found in hospital water distribution systems.
Patients most at risk at contracting M kansasii are those who have underlying diseases such
as pneumoconiosis, chronic lung disease, previous mycobacterial disease, malignancy or
alcoholism. Identification of these isolates can be performed using both genotypic and
phenotypic analysis; the more common phenotypic characteristics include positivity for
catalase, nitrite reduction and Tween 80 hydrolysis.
• M ahscessus
This is a pathogenic RGM, and the fourth most common mycobacterial pathogen to
be associated with respiratory disease. It is the cause of more than 80% of all pulmonary
diseases caused by RGM . M ahscessus is more commonly associated with skin, soft tissue
and bone disease. It has also been associated with wound infection and abscess formation in
immunocompromised patientsIt is notable for its resistance to antibiotic treatment and
poor clinical outcome, making the identification of these bacteria to a species-level of greater
importance. Identification of this RGM can provide the first indication regarding the most
effective antibiotic therapy, and can improve overall patient management. Sputum samples or
lung biopsies can be used to test for the presence of M ahscessus in the lungs, where fluid
from abscess or biopsies of skin and bone samples can be used to check for the presence of
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these bacteria in other parts of the body. Once the samples are cultured, a series of
biochemical tests and molecular methods may be used for identification. A few specific
biochemical tests can help determine between M. ahscessus and other ROM, including 3-day
arysulfatase test, iron uptake, nitrate reductase activity and the utilisation of carbohydrates
mannitol, inositol, and citrate''.

1.3. IDENTIFICATION OF MYCOBACTERIA
1.3.1 Introduction
Identification of mycobacteria is a time-consuming, expensive and laborious task.
Initially, clinical samples are examined microscopically, using the Ziehl-Neelsen (ZN)
staining technique. This involves Carbol-Fuchsin staining solution which is able to break
through the lipid-rich wall of any mycobacterium. The dye is not removed during a washing
step with alcohol. Finally, a counter-stain with Methylene Blue is used to check for
contamination. The major advantage of the ZN stain is its ability to directly test samples for
the presence of mycobacteria without the need for culturing. It is one of the first steps in the
diagnostic process, a brief outline of which can be seen in Figure 1.5. Once a sample is
deemed ZN positive the next process is to decontaminate and culture the specimen.
Subsequent analysis requires long-term cultivation prior to the identification of a definite
species using a range of phenotypic and genotypic tests. Due to the slow-growing and
fastidious nature of the mycobacteria this can take several weeks, which has a significant
negative impact on the patient treatment options. Only once all this is completed can
phenotypic and molecular tests be performed to confirm the identity of the isolate.

Cui
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e.g. Sputum
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culturing of sample
MGIT960
BACTEC
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2-3 weeks

Biochemical
Analysis 2-3
weeks

Testing for
mycobacteria is
complete

J

Molecular
identification
1 day

Figure 1. 5 Brief outline of Clinical Analysis of Mycobacteria

Many clinical and hospital laboratories are now using the BACTEC™ or MGIT
960^*^ system for cultivation and analysis of mycobacteria. These automated in vitro
diagnostic instruments are designed and optimised for the rapid identification of
mycobacteria from clinical specimens. The systems operate on a high throughput capacity
and are useful in laboratories dealing with large specimen load^'^’

They provide

continuous monitoring of patient samples to identify positives and deliver safe, on-board
incubation. Both systems are costly, and are not always available in smaller laboratories
where economical resources are limited . Similar to the ZN stain, these systems are
generally indicative of mycobacteria being present in the clinical sample, with the added
advantage of generating a relatively pure liquid culture over several days or weeks. Once a
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sample is confirmed positive further species-specific tests can be carried out, depending on
the resources and expertise of the individual laboratories.
There are now several commercial systems using various technologies that can be
used in clinical laboratories, for the detection of mycobacteria species. Including the INNOLiPA mycobacteria assay (Innogenetics), the Cobas Amplicor PCR system (Roche), the
HAIN''^’^ DNA probe (Hain lifesciences), and the BD ProbTec strand displacement
amplification (Becton Dickinson)*^^.
1.3.2 Phenotypic identification ofNTM
Once significant biomass has been generated, several options are available in terms of
species and subspecies identification These include several phenotypic studies, including
growth rate, colonial morphology, pigmentation, biochemical profiles, and gas-liquid
chromatography of short chain fatty acids*These traditional methods for the identification
of mycobacteria were built on the Runyon's Classification system as described earlier in this
review, and required the culture to be present in a pure format.
The drawback to Runyon’s classification is its inability to distinguish between closely
related species of mycobacteria such as M ahscessus and M. chelonae. The consequence of
this is the potential to prescribe incorrect antimicrobial treatment in patients.
There are many biochemical tests used in the identification of mycobacterial species.
A representation of these tests include nitrate reduction, catalase production, catalase
inactivation at 68"C, hydrolysis of Tween, reduction of potassium tellurite, tolerance of 5%
NaCl, iron uptake and urease production*These conventional biochemical assays are
considered cumbersome, laborious and time-consuming, with many tests taking 2-6 weeks
for completion**^. A further complication is the need to cultivate the bacteria before analysis
which, as previously mentioned, can take several weeks.
One such phenotypic method developed for the species identification of
mycobacteria was high-performance liquid chromatography (HPLC). It was proposed in 1985
and introduced into the laboratory during the late 1980's, with the principle based on the
analysis of mycolic acids present in the cell wall. The method reduced the time from several
weeks to days, and became the standard for the Centre for Disease Control (CDC) in 1990 .
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In 1994 the CDC developed a database of chromatograms that contained 45 species; with an
accuracy of 97%. Although the methods are rapid and the results may be available within two
hours, instrumentation is costly and trained personnel are necessary to perform analyses'^'^.

1.3.3 Molecular identification ofNTM
Several different molecular methods have been developed in recent years, allowing
the identification time of mycobacteria to be decreased dramatically from several weeks with
biochemical tests to a number of hours with molecular analysis. The more common molecular
methods generally identify mycobacteria to a species level. This usually involves either a
manual PCR-based method such as 16S rRNA gene analysis, or an automated probe based
assay like the HAIN^"^ test. This method is particularly useful for large scale high throughput
screening in a clinical laboratory.
A DNA STRIP® is coated with highly specific probes which are complementary to
selective species specific nucleic acid sequences. The single-stranded isolated DNA binds
specifically to the probes during hybridisation, while the non-specifically bound amplicons
are removed during a washing step. The final outcome is the development of a specific
profile on the DNA STRIP. Results are then compared to a reference template, a sample of
which can be seen in Figure 1.6. This enables the mycobacterial pathogen present to be
determined. For the identification of mycobacteria, several assay kits are available to use for
the identification of mycobacteria species including Genotype Mycobacteria CM/AS,
Genotype® Mycobacteria MTBDRs / MTBDR plus (http://www. hainlifescience.de/en/technology). This technology has the ability to identify 44 species of
mycobacteria including all clinically important species, and it is also able to distinguish
between species pairs with identical 16S rRNA sequences .
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Figure 1.6 Illustrating a HAIN DNA STRIP® (http: //www. hainlifescience.de/en/technology)
Unlike biochemical methods, molecular identification requires the extraction of DNA
from the clinical sample being tested, or preferably from an isolated colony. Extractions are
generally carried out using powerful lysis buffers that break down the cell, or mechanical
techniques such as grinding with acid wash beads. Once DNA is obtained. Polymerase Chain
Reaction (PCR) may be performed, which allows for the amplification and visualisation of
the DNA. For non-amplified molecular methods, sufficient DNA biomass must be generated
through prior decontamination and propagation in the lab.
More recently, PCR has become the main diagnostic tool in many clinical and
research laboratories, due to its ability to produce rapid and reliable results. Several studies
have been carried out showing the efficiency of PCR. One such study is reported by Leung et
al^^ who developed a simple low-cost real-time PCR method for the identification of
commonly encountered mycobacteria in a high throughput laboratory. Another is
demonstrated by Lee at al*""^ comparing the utility of the GenoType Mycobacterium CM/AS
assay with HPLC and 16S rRNA gene sequencing for the identification of NTM.
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L3.4 16S rRNA gene analysis to a species level for mycobacteria.
In the 1980's a new standard for identifying bacteria began to develop. It was
considered that phylogenetic relationships could be determined by comparing conserved parts
of the genetic code^^. The part of the DNA now most commonly used for taxonomic purposes
is the 16S rRNA gene. This gene is approximately 1,500 nucleotides in length, and is
composed of both variable and conserved regions. The gene is large enough, with sufficient
interspecific polymorphisms, to provide distinguishing and statistically valid measurements’^.
Sequencing of the 16s rRNA gene can be performed using specific primers such as 285F and
264R^ (See Figure 1.7), or commercial kits like MicroSeq 500 16S rDNA protocol kit””’
The advantage of the 16S gene sequence is that it has been determined for a large number of
strains. GeneBank is the largest databank of nucleotide sequences, with over 20 million
deposited sequences of which over 90,000 are of the 16S gene. In the mycobacterial 16S
rRNA gene the nucleotide stretches which are the most useful are the ones shared by all
members of the genus Mycobacterium^ and also the hypervariable regions, characterised by
species specific variability. The 16S rRNA- based genetic investigation of mycobacterial
taxonomy and phylogeny focuses on two hypervariable sequences known as region A and B.
While slow growers contain one copy of the 16S rRNA gene, rapid growers contain two, with
the exception of M abscessus and M. chelonae

.

Recently another database was established known as Ribosomal Differentiation of
Medical Microorganisms (RIDOM), and is currently available at (http://www.ridom.de). The
service contains not only sequenced data but also additional information such as clinical data,
phenotypic and genotypic characteristics, and related references for each species established
1 'y/r

as well as non-established
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264

285

(1027-1046)

(9-30)

1

broad-range

genus specific

16S RXA

J^L

H>pervariable region A

1,

I,

,!

H\perv ariable region B

ZGAATAGGACCGC-ATGCT-CCATGGTGTG-TGGTGGAAAGCT

16S Non Chromo(l>1367)

ilGTATCGGCGAAGCTCCAAGGTTTT-CnTGGGGTGACGGTAGGTACAGAAGAj

:gaataggaccgc-atgct-tcatggtgtg-tggtggaaagct

16S Terrae(l>1321)

HGTATCGGCGAAGCTCCGGGATTTTTCTT-GGGGTGACGGTAGGTACAGAAGAi

:GAATASRHCCtGCaTGSTYgCATGGYSTGgTRGKGGAAAGCT

16S Arupense(l>i082)

HGYAYMGRCGAAGCtccGggatttttCW-GgggTGACGGTAKGTRCAGAAGAi

:ggataggaccgc-gcgct-tcatggtgtg-tggtggaaagct

16SHiberniae(l>1206)

iGTATCGGCGAAGCTCCGTGGTTTT-CTGCGGGGTGACGGTAGGTACAGAAGAi

:GAATACAC C CTGCTGGTC-GCATGGC CTGGTAGGGGAAAGCT

16S Smeg(l>1204)

iGCACAGACGAAGCGCA-------------------------------- AGTGACGGTATGTGCAGAAGAi

:GGATAGGAC CAC-TTGGC-GCATGc C CTTGTGGTGGAAAGCT

16S Kansas!i(l>1063)

ACCATCGACGAAGGTCCG-GGTTCT-CT-CGGATTGACGGTAGGTGGAGAAGAi

:GGATAGGAC CTC-AAGAC-GCATGTC-TTCTGGTGGAAAGCT

163 MAC(1>1032)

UCCATCGACGAAGGTCCG-GGTnr-CT-CGGATTGACGGTAGGTGGAGAAGAi

:GAATAGGAC C C C GAGGC —• GCATG-C CTTGGGGTGGAAAGCT

163 Maliaoense(l>1037)

AC CATC GAC GAAGGTC C G-GGTTTT-CT-C GGATTGAC GGTAGGTGGAGAAGAi

:GGATAGGACCTC-AAGAC-GCATGTC-TTCTGGTGGAAAGCT

163 HAP isolates(1>993

ACCATCGACGAAGGTCCG-GGTTTT-CT-CGGATTGACGGTAGGTGGAGAAGAi

:gaataggaccac-agaac-acatgtcctg-tggtggaaagct

163 GoEdonae(l>1024)

AC CATC GAC GAAGGTYC G- GGTnT- CT- C GGRYTGAC GGTAGGTGGAGAAGAi

:GAATATGAC CAC-GC GCT-TCATGGTGTG-TGGTGGAAAGCT

163 roEtuitm(l>1006)

AATAGGGAC GAAGC GC AA- G-TGA- - C - — GG-TAC - C —TA—TAGA-A- GAi

:ggataggaccac-acact-tcatggtgag-tggtgcaaagct

163 Abscessus(1>1246)

AGTAGGGACGAAGCGAA-------------------------------- AGTGACGGTACCTACAGAAGAi

:ggataggaccac-acact-tcatggtgag-tggtgcaaagct

163 Chelonae(l>1198)

AGTAGGGAC GAAGC GAA-------------------------------- AGTGACGGTACCTACAGAAGAi

Figure 1.7 16S gene showing hypervariable regions A and B for specific species of NTM
More recently, there have been several additional studies comparing the identification
of mycobacteria by 16S rRNA gene sequence and phenotypic methods^'^. In all of these
studies, the accuracy of 16S rRNA gene sequencing for the identification to the species level
was judged to be greater than any phenotypic methods. The sequencing of the 16S gene is
specific and is still considered a gold standard for identification'^^’

Studies also prove that

16S ribosomal rRNA sequenced based identification methods for the identification of
mycobacteria, are more rapid (hours versus weeks) and much less time consuming than some
phenotypic methods

1 9A

Several mycobacterial related molecular studies have been carried out over the years
for the typing of clinical isolates, such as Woo et al

who used 16S rRNA gene sequencing

for bacterial identification and discovery of novel bacteria in clinical microbiology
laboratories. Dwivedi et al^^ used computational identification of composite regulatory sites
in 16S-rRNA gene promoters of Mycobacterium species and Richardson et al’°^ used the 16S
gene for rapidly identifying TB and NTM by multiplex real-time PCR.
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As mentioned earlier the 16S rRNA gene is well accepted when it comes to
identifying mycobacteria to a species level. However several sub-groups of mycobacteria
have emerged in recent years, for example MAC, whereby the 16S gene is unable to identify
past the species level. Consequently other molecular methods have been developed which
have an extra layer of discriminatory power. These include Insertion Sequences (IS)
profiling, and Sequevar analysis using the hsp65 gene.
13.5 Insertion Sequence (IS) profiling
This is useful for tracking lineages within a species such as MAC and has also been
used to assess virulence among cohorts of isolates. For example, IS 1245 is regarded as a
virulence determinant in M avium, subsp. hominissuis^. IS are mobile DNA elements that
can produce various types of genome rearrangement, such as deletions, inversions,
duplications, and replicon fusions, by transpositions within the genome. Most IS are 8002,500bp long, contain one or more open frames, and encode a transposon which mediates
movement of the element'^'^’Several IS which are species specific have been used for the
typing of different mycobacteria strains, and include IS901^®, IS1245^ IS900^ and IS 1311^.
As well as the use of 16S rRNA gene analysis for identifying NTM, it was thought that IS or
internal transcribed spacer sequence could also be used for identification and profiling.
Several IS elements have been described over the years for the identification of MAC isolates
including:
IS900, which was the first element to be characterised for the Mycobacterium genus
and is used for the identification of Mycobacterium avium subsp paratuherculosis (MAP).
Kunze et al discovered the IS901 in diseased birds and animals with microscopic
lesions^^. It has been shown that isolates found in birds are more virulent than isolates that
have been found in HIV-infected individuals*^^.
IS1311 was first identified in 1994, and is an element that is considered present in all
members of the MAC group; therefore it is useful in confirming the presence of MAC from
clinical sources*^^.
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IS 1245 was first discovered in 1995 and was considered to have more of a restricted
range than IS1311. It is also thought that only virulent isolates oiM avium subsp. hominissuis
contain high numbers of this element^.
1.3.6 hsp65 gene and Sequevar analysis to a sub-species level
hsp65 gene profiling has proved to be well suited for the molecular typing of the
mycobacterial isolates, specifically MAC. It was initially considered because the hsp65 gene
is also present in all mycobacteria. However, hsp65 gene profiling is considered more
variable than the 16S rRNA gene sequence, and is therefore potentially useful for the
identification of genetically related species’^^. Sequence variation in the hsp65 gene can be
exploited to identify both ROM and SGM to a species level.
The hsp65 gene also has hypervariable regions, whose sequence may be used for
identification and is generally employed by taxonomists because of the enzyme pattern of the
polymorphic profile of much of the >l,600bp complete gene. Telenti et al*'^ first
implemented the method, and sequencing of the 441 bp fragment is able to differentiate
among the great majority of species of mycobacteria (See Figure 1.8 below). The hsp65 gene
has now become a routine method for taxonomical studies 74,96
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Figure 1.8 Alignment of hypervariable regions of the partial hsp65 gene, represents the
position within the complete hsp65 gene in M. tuberculosis followed by the position
within the amplified 441-bp fragment
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Initial analysis was performed using a 960-bp fragment of the hsp65 gene along with
an in silica analysis of the groEL2 gene, which was then compared to the corresponding

M.avium 104 genome sequence. This revealed the presence of 11 single nucleotide
polymorphisms (SNPs) thus showing that using the hsp65 gene, could be used as a
genotyping method for the systematic identification of the various MAC subsets.
Consequently these SNPs allowed the MAC species to be divided into groups known as
sequevars. Sequevars can now distinguish between M avium subsp. avium, MAP, M avium

subsp. hominissuis, M. avium subsp. silvaticum andM intracellular.
Fourteen different sequevars were determined to exist from a study carried out by
Turenne et al*^^. Since then 35 sequevars have been identified including MAVA to -H for the
species M avium, MinA to -D for M intracellulare, and MAC-A to -X for strains which
could not be assigned to either^^^. The amplification of these genes in combination has
improved the molecular identification of all mycobacterial isolates, and has led to a higher
discriminatory power in analysing the 3’ region of the hsp65 gene. This allows for several
epidemiologically important members of the MAC to be identified and classified into their
own lineages. Pourahmad et al^^ carried out comparative analysis of the hsp65gQnQ for the
identification of aquatic mycobacteria, while Senna et al’®^ used the sequencing of hsp65
gene for the identification of mycobacterium species isolated from environmental and clinical
sources in Rio de Janeiro, Brazil. Martin et af"^ used hsp65 PRA for the identification of
mycobacteria from clinical isolates, while Ringuet et al used hsp65 sequencing for the
identification of ROM. Williams et al*^^ used hsp65 and 16S rRNA typing for the
identification of clinical NTM isolates. Another clinical based analysis was carried out by
Bum-Joon Kim et al’^ who designed a duplex PCR for the rapid identification of
mycobacteria in sputum. These and many other studies illustrate the usefulness of molecular
analysis in modem laboratories.

1.3.7 Clinical and epidemiological information
As mentioned earlier, NTM infections generally infect immunocompromised individuals.
Recent studies have shown two high-risk categories, firstly, HIV infected individuals and
secondly patients suffering from cystic fibrosis^\ Other factors such as gender and age can
also influence the chance of infection.
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Generally, middle age men are more susceptible to NTM infection than women"^^,
mainly due to lifestyle choices. A study by Bodle et al (2008) has shown that age plays a
factor in NTM infection. Specifically this study showed 59% of infected individuals were
greater than 60 years, while only 8% of cases occurred among individuals less than 15 years.
The most common site of infection for NTMs is the respiratory tract^, while isolation from
other sites such as orbital implants is far less common. According to the latest study carriedout by the CDC, the incidence of NTM in the general population is 2% per 100,000
individuals^^, although it is believed that this figure is on the increase in many countries. It is
necessary, therefore, to continually perform surveillance studies to monitor trends in NTM
infection worldwide.
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1.4 ENVIRONMENTAL NTM
1.4.1 Introduction
Much of the research carried out on NTM is clinical or hospital based. This is mainly
due to the ability of NTM to cause nosocomial illnesses and chronic infections in the
immunocompromised. However, since all mycobacteria originate from environmental
sources it is necessary to outline their role and function in these ecosystems. Studies have
suggested that mycobacteria found in water are known to cause infection in humans^^’
Other studies focus on the ecology of NTM and their ability to survive in any habitat,
including extreme

The next section looks at the ecology of environmental NTM,

and their ability to cause infection.
1.4.2 Ecology of NTM in the environment
Environmental mycobacteria (EM) are normal inhabitants of a wide variety of
habitats including natural and municipal water, soil’^^, and also in dust, rocks and
bioaerosols. They are considered ubiquitous in nature, and have been increasingly identified
from environments with harsh conditions such as low nutrients, low pH and temperature
extremes . Recently it has been determined that EM can multiply in the numerous water
sources available in the environment, including wastewater, surface water, recreational water
(swimming pools), ground water and tap water”. Most NTM in the environment are
considered saprophytes, and generally are non-pathogenic. There are a few known to cause
disease in humans, and they are outlined below. EM can be divided into the same groups that
were outlined in section 2.
1.4.3 Common NTMfound in water
The species M. avium, M. chelonae, M. fortutium, M. gordonae, M. marmum and M.
ulcerans are some of the most frequently reported mycobacteria occurring in water^*’

All

of these species are proven pathogens, mainly in immunocompromised people. There has
been a correlation between environmental mycobacterial infections and clinical mycobacteria
mainly due to their ability to be transmitted via water.
Many of the mycobacteria that can be isolated from hospital sources can also be
extracted from common water supplies such as rivers, lakes, streams, and wells. Several of
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the NTM that are known to cause infections in hospitals can also cause disease directly from
the environment. The difference is that infection acquired from NTM m the environment
generally requires long-term exposure to the pathogen before infection can take hold,
compared with nosocomial infections that only require short-term exposure with the
pathogen. Table (1.3) lists some of the more common mycobacteria regularly extracted from
the environment that may be potentially infectious in humans.

NTM Associated with the Environment
Species/group

Ecology

Associated Infection

M. ahscessus

Tap Water

Pulmonary, Skin and Soft Tissue

M. chelonae

Tap Water

Skin and Soft Tissue

M. flavescens

Rivers

Non-pathogenic

M. fortutium

Tap Water

Skin and Soft Tissue

M. gordonae

Rivers

Non-pathogenic

M. marinum

Salt Water Fish

Skin and Soft Tissue

M. murale

Rivers

Non-pathogenic

M. tokaiense

Rivers

Non-pathogenic

M. niceruns

Rivers

Ulcers

M. xenopi

Hot Water Systems

Pulmonary, Skin and Soft Tissue

MAC

Tap Water

Pulmonary

Table 1.3 Listing Common Mycobacteria found in the Environment*^®
1.4.4 Sources of NTM in the Environment
The purification and characterisation of EM directly from water has benefited
enormously from advances in biotechnology as outlined below. There are now several
methods available to extract mycobacteria directly from water, including commercial kits,
chemical extraction, and extraction by filtration. It has also been determined that
environmental mycobacteria are exceptionally resistant to disinfection with chemicals such as
chlorine’^'*. It is this ability to survive disinfection that allows them to survive in treated water
systems. Furthermore, they are also able to create biofilms, which offer suitable nutrient
conditions and protections against disinfection. Although EM have been shown to cause
disease in humans, infection is usually only seen in immunocompromised hosts. Infections
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are commonly obtained from drinking or bathing in contaminated tap water, or from contact
with contaminated medical equipment.
1.4.5 NTM from the environment that are known agents of infection
Some of environmental NTM that are known agents of infection are listed in Table
1.3 however two of the most common include Mycobacterium ulcerans and Mycobacterium
marinum both of which are outlined below.
Mycobacterium ulcerans is a slow-growing environmental bacterium that causes a
severe skin disease known as Buruli ulcer. The disease has been reported in over 30 countries
worldwide, predominantly in riverside areas with tropical and subtropical climates, but also
in temperate climates, such as southern Australia. Infection with M. ulcerans can lead to
extensive destruction of skin and soft tissue with the formation of large ulcers^^’
Mycobacterium marinum is another waterborne mycobacterium that commonly
infects fish and amphibians worldwide. Infection in humans occurs occasionally, and in most
cases as a granulomatous infection localised in the skin, typically following minor trauma on
Q9

the hands .
1.4.6 Ability ofNTM to form Biofilms
A biofilm is a microbial community characterised by cells that are irreversibly
attached to a substrate or interface with each other. They are embedded in a matrix of
extracellular polymeric substances that they have produced, and that exhibit an altered
phenotype with respect to growth rate and general transcription . The formation of biofilms
can be regarded as a universal bacterial strategy, and optimum positioning with regard to
available nutrients. Biofilms are more resistant to antimicrobial agents than planktonic cells.
Restricted penetration of the antimicrobial into the biofilms, decreased growth-rate and
expression of possible biofilm-specific resistance genes are mechanisms which, alone or in
1

combination, explain biofilm survival
The mechanism of biofilm formation by mycobacteria is not fully understood, and has only
recently been studied^^. Environmental mycobacteria lack surface structures such as flagella,
pili, fimbrae, slime or capsules as surface translocation modes. They achieve spreading on
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surface by a sliding mechanism. This form of motility is likely to play an important role in
the surface colonisation in the environment as well as in the host.
Mycobacteria-containing biofilms have been found in water meters, which are usually
placed at distal sites of the distribution system. Many species of mycobacterium such as
M aurum, M avium, M. gordonae, M. haemophilum, M. intracellulare, M. marinum and M

terrae have been recovered from water meter biofilm samples ^

The type of surface may

have an effect on mycobacterial biofilm numbers; for example, numbers of M intracellulare
were 400cfu/cm^ on brass or bronze surfaces compared to 70cfu/cm^ on plastic^^.

1.4.7 Sampling
The main purpose of sampling is to obtain a sample from a specific environment that
is said to represent that environment'*'^. When taking a water sample it is necessary to ensure
that a bulk representative aliquot has been obtained from the aquatic area being sampled.
Depending on the investigation being carried-out, several samples may be required over a
predetermined time. Other studies may only require one sample but may take other
environmental factors into consideration, such as pH, weather and pollution. For example,
Falkinham et al^^ collected 300ml of water per sample in a study, whereas Le Dantec et al^^
collected lOOOmls per sample when collecting water from surface and ground water sources
for the detection of mycobacteria. Figure (1.9) illustrates a flow chart of the analysis process
of water from sample-to-result identification, based on a process outlined by Stinear et al""*.
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Sample Preparation
Sample type: water, soil.
Collection method
Logistical consideration: volume,
pH, frequency

V
Sample Storage
• Temperature
• Time

Sample Preparation
Concentration, centrifugation,
filtration
Purification and decontamination

Cultivation
Incubation temperature
Time: days, weeks, months

Detection and analysis
• Microscopy
• PCR DNA direct from water / from
cultivated sample
Species identification

Figure 1.9 Flow chart of the analysis process of water from collection to identification 114
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1.4.8 Isolation

Mycobacteria are usually present in water at a relatively low concentration, making
isolation from water difficult. Isolation of many mycobacteria from water requires a
combination of methods usually involving concentration and decontamination.
- Filtration and centrifugation
Filtration and centrifugation can be used for the concentration of mycobacteria in a
water sample. Often water samples may contain other organisms that would be capable of
overgrowing the mycobacteria colonies; therefore a decontamination step is required during
the processing of these samples. If centrifugation is the method being used for concentration,
the pelleted cells can either be suspended in a small volume of water or suspended in a small
amount of the original sample. Filtration allows for minute quantities of bacteria in large
volumes of water to be concentrated down onto a single filter. Once all the bacteria are
collected, they can either be extracted and decontaminated prior to cultivation, or the filter
can be decontaminated directly and placed on to agar for growth’
- Decontamination
Once concentration of the sample has been performed, decontamination can
commence. Since mycobacteria are present in such small quantities in the water, it is
necessary to kill off other contaminants present in the sample to allow for the cultivation of
mycobacteria and prevent inhibition from other bacteria. Decontamination agents often
include NaOH, oxalic acid, HCl, CPC, and HPC^’”. Due to the harshness of the treatment,
many mycobacteria may also be killed during decontamination but to a lesser extent,
indicating that only a minority of the total population of waterborne mycobacteria in a sample
can be recovered. It is therefore necessary to optimise decontamination methods on water
samples containing a known concentration of mycobacteria. It is considered that if the water
samples being tested were undergoing filtration, then the samples should be disinfected prior
to filtration‘s^, and the filters placed directly onto the media plates. However, more recent
studies carried out suggest disinfection post filtration, by suspending the filter in a small
volume of water and removing the cells off the filter .
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1.5 Mycobacteria research in Ireland.
Most of the mycobacterial research that has been performed in Ireland over the last few years
has been based around the impact of mycobacterial infection in animals. Such examples
include the prevalence of MAP in milk^*", and the incidence of M. hovis in Irish dairy herds^.
Some of the clinical research programmes examined how M. bovis infections were causing
smear positive TB results in humans in Southern Ireland. It was postulated that the presence
of M. bovis in contaminated milk products may have been the cause of this.
One single study has been carried-out in Ireland on the incidence of NTM in clinical
environments. Kennedy et al^^ preformed a 14-year review from, 1987-2000, on the
incidence of NTM in Southern Ireland, which examined epidemiological characteristics.
Comparisons were also made against the incidence ot TB and M. bovis infections. Results
illustrated that cases of NTM infections were on the rise (0.4/100,000 population). This
however reflected global trends which may be due to an increased ageing population,
increased incidence of chronic fibrotic lung disease, and environmental mycobacterial
factors. This study did not perform any molecular analysis on the mycobacteria, and to-date
no other study has been completed to illustrate the rise or molecular diversity of NTM in
clinical environments in Ireland. Since NTM infections are increasing annually worldwide, it
is timely to undertake this study, which set out with a clear number of objectives;
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Objectives

39

Overall objectives:
A series of objectives was planned for both clinical and environmental analyses, which are
outlined below;
Clinical
> To assemble and cultivate a large range of clinical NTM isolates from the C.U.H and
St James' Hospital, Dublin (n=l00).

> To perfohn a broad epidemiological analysis on patient information provided by the
C.U.H. (n=50).

> To identify all 100 mycobacterial isolates to a species level, using 16S rRNA
molecular profiling, and to
>

evaluate molecular analysis against lab-based identification carried out by both
hospitals.

> To compare the performance and reliability of sequence databases BLAST and
RIDOM.

> To generate a molecular profile for a defined number of MAC isolates (n=66) using
IS profiling and hsp65 sequevar analysis.

Environmental

> To optimise and implement a decontamination procedure for routine processing of
environmental water samples.

> To assemble an environmental bank of NTM isolates, by isolating and propagating
NTM from a variety of water sources.

> To identify and confirm suspect NTM colonies by 16S molecular profiling.
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Chapter II
Materials and Methods
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2.1 COLLECTION AND CULTIVATION OF HOSPITAL ISOLATES

2.1.1. Bacterial Strains
A total of 100 mycobacterial isolates were obtained from two individual sources. Cork
University Hospital (CUH) donated the first batch of 50 isolates in 2007, which were
received on Ldwenstein-Jensen agar slants. The second batch was donated by St James
Hospital Dublin, and consisted of 50 isolates received during March-May 2009. These
isolates were provided in Middlebrook broth. From both sources a bank of clinical
isolates was generated which consisted of 10 different species of mycobacteria
including both SGM and ROM as shown in Table 2.1.
Original Number of strains in clinical bank
No.

No.

M abscessus

4

MAC

71

M. chelonae

8

M. malmoense

2

M fortutium

1

M smegmatis

1

M. gordonae

3

M. terrae

4

M. kansasii

4

M. xenopi

3

Table 2.1 Showing original Strains of Isolates in the C.I.T Bank^

Cork University Hospital had also provided clinical data on all 50 of their isolates,
which were categorised under the following headings.
1. Date of isolation.

5. Date of birth (DOB).

2. Site of infection.

6. Isolation Number.

3. Age of patient.
4. Gender of patient.

This provided data that could be used for epidemiological analysis later-on in the study.
Since very few studies have been performed on the prevalence of NTM in clinical

7 isolates M>ere reclassified after 16S rRNA typing, identifying 4 more strains of mycobacteria;
these can be seen in Tables 3.4 and 3.5 of the results.
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environments, it was considered appropriate to determine trends in an Irish hospital
setting.

2.1.2 Media Preparation.
As stated earlier in section 1.1.3, mycobacteria are extremely difficult and fastidious to
cultivate. Unlike E.coli, which produces colonies within 24 hours of incubation, the
faster growing mycobacteria in this collection took an average of 48 - 72 hours to form
colonies, with many of the isolates in this study taking on average 2-3 weeks to grow.
Other SGM isolates took 6-8 weeks to form colonies. To ensure the shortest
cultivation time for all mycobacteria it was prudent to implement optimum growth
conditions. The first step was to choose a media that contained all the required nutrients
for growth. Middlebrook 7H10 was used for growing mycobacteria, combined with
glycerol and OADC supplement (Oleate-albumin-dextrose-catalase), which was
prepared as outlined below. As most mycobacteria grow well at 37‘'C, all plates and
broths were incubated at this temperature. All broths were placed in shaking incubators
for optimum growth.
• Middlebrook Broth
4.7g of Middlebrook broth was dissolved in IL of distilled water, along with 2mls of
glycerol which was then autoclaved at 121*^0 for 15min. Once cooled to 50''C, lOOmls
of OADC supplement (10% final volume) was added.
• Middlebrook agar
4.7g of Middlebrook broth and 15g of agar was dissolved in IL of distilled water, along
with 2mls of glycerol which was then autoclaved at 12UC for 15min. Once cooled to
50°C OADC supplement (10% final volume) was added.

2.1.3. Propagation ofNTM
• Cork isolates:
Cork isolates were provided fully cultured with pure colonies on Lowenstein-Jensen
agar slants. Colonies were aseptically removed and either streaked onto Middlebrook
agar or inoculated into lOmls of Middlebrook broth and supplement. Plates were
incubated at 3TC. ROM were examined every day for one week - ten days until
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colonies were clearly visible. SGM were examined twice a week until colonies had
formed, the slowest species taking 8 weeks to grow.
Broths were incubated at 3>TC in a shaking incubator. Once cultivated, plates and broth
were stored at 4®C. Colonies were stocked at -20"C and -80”C respectively.

• Stocking
This involved aseptically removing a colony under the laminar flow hood and placing it
in a cryo-protective tube containing 1ml of sterile glycerol (40% final concentration).
Tubes were then placed at either -20°C or -80 °C. This procedure was necessary to
ensure a pure isolate of each sample was available for cultivation at any time
throughout the project.

• Dublin isolates:
Dublin isolates were provided m 2mls of Middlebrook broth. Loops of the inoculum
were aseptically streaked onto Middlebrook agar plates and incubated at 37"C, or
inoculated into lOmls of Middlebrook broth, which was also incubated at 3TC. Their
growth was observed as outlined above. The Dublin isolates were generally more
difficult to culture, and several propagations were required to ensure pure culture.
After successful cultivation of each sample the morphological characteristics such as
colony colour, texture and growth profile were observed and recorded.

2.2 MICROSCOPIC CHARACTERISATION OF NTM

2.2.1 Ziehl-Neelsen Stain for Acid-fast Bacteria (AFB)
This is considered the preferred method when carrying out microscopic analysis of the
clinical isolates, and is capable of penetrating through the particularly thick cell wall of
any mycobacteria It is also used as the first identification tool for clinical isolates due
to the stain's ability to be directly used on clinical specimens e.g. sputum samples.
During this study two ZN methods were carried-out, the Hot and Cold method. All 100
isolates were stained to confirm their identity and purity.
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Materials
•

Carbol-Fuchsin solution (2.5g basic fuchsin, 250mls distilled water, 25mls
100% alcohol 12.5mls Phenol crystals melted).

• Methylene Blue solution (0.7g Methylene Blue, IN 50mls Distilled Water).
• 3% Acid Alcohol (30mls Hydrochloric acid, 970mls 70% alcohol).
• Methylene Blue Acid Alcohol solution (Ig Methylene Blue 20% Acid 30%
alcohol, distilled Water).

•

Hot method
1. A glass slide was heat sterilised by passing it through a Bunsen fiame, before a
drop of distilled water was aseptically placed in the centre.
2. A colony of mycobacteria was aseptically taken from an agar plate and smeared
onto the slide.
3. The smear was allowed to air-dry, before being heat fixed onto the slide.
4. The hot plate was turned on full (60‘'C) and covered in tin foil. The glass slides
which were placed on top were flooded with the Carbol-Fuchsin solution for 5
minutes before being rinsed with distilled H2O for 30 seconds.
5. An acid-alcohol solution was used to decolour the slides, which were then rinsed
for 30sec.
6. Methylene Blue was used as a counter stain. Slides were flooded with the dye
for 2 - 3min and rinsed with distilled water. Slides were allowed to air-dry
before observing them under the microscope with immersion oil at 1OOX
magnification.

Cold Method
1. Steps 1-3 were followed as stated for the Hot Method.
2. Slides were flooded with Carbol-Fuchsin solution for lOmin.
3. Slides were then rinsed with distilled water for 30 - 40sec.
4. Methylene Blue acid alcohol solution was used as the counter stain for 2 -3min.
5. Slides were rinsed once more with distilled water and allowed to air dry.
6. Observation was performed under the microscope at lOOX magnification.
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2.3 MOLECULAR ANALYSIS OF NTM

As referred to earlier, molecular analysis is a more versatile and informative way of
identifying mycobacteria. Molecular analysis involves several steps, including DNA
extraction, PCR and sequence analysis.

2.3.1 DNA extraction by GITC lysis.
A powerful extraction method capable of breaking down the mycobacterial cell wall
was used to extract DNA from the clinical isolates. The GITC (guanidinium
isothiocyanate) lysis method^^ uses a lysis buffer to help penetrate the mycolic acids in
the thick cell wall. This, along with a mechanical treatment using acid-washed glass
beads and a MagNA lyser^'^ (Roche), was used to extract DNA.

Materials
•

GITC lysis buffer (IM Tris, 0.5M EDTA, 0.3M Na acetate, 6M GITC 2%,
Triton lOOx and H2O to a final volume of 50ml).

•

Acid washed glass beads (Sigma).

•

Phenol; chloroform; isoamly alcohol (25; 24; 1; Sigma).

•

MagNA lyser™ (Roche).

•

Isopropanol (Sigma).

Methods
1.

A 10ml falcon tube containing bacterial culture was vortexed. One ml of
bacterial culture was removed and transferred to a 1.5ml eppendorf. This was
centrifuged at I4,000rpm for 10 minutes.

2.

After removing the supernatant, the pellet was suspended in 750pl of GITC lysis
buffer, and the mixture was transferred to a 2ml screwcap eppendorf containing
300mg of acid-washed glass beads.

3.

The tubes were processed in the Magna lyser^^* (Roche) or bead beater for Imin
at top speed. Tubes were placed on ice for approximately 5min.

4.

Subsequently, the tubes were boiled briefly for three minutes, returned to ice and
centrifuged briefly to collect the beads. 650pl of the supernatant was removed
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and precipitated with equal quantities of phenol-chloroform isoamyl alcohol
(under a chemical hood).
5.

Tubes were then vortexed for 10 - 15sec, and centrifuged for 30sec at
14,000rpm.

6.

The top layer was removed and precipitated with 650pl of cold isopropanol. The
tubes were centrifuged again at 13,000rpm for 25 - 30min.

7.

Finally, the supernatant was removed and the pellet was allowed to dry. Once
dry, the pellet was re-suspended in lOOpl of nuclease free water (NFW). The
DNA was stored short term at 4®C.

•

Extraction of DNA by boiling

Boiling was carried out as a more rapid method of DNA extraction when preliminary
molecular analysis was needed. A colony of bacteria was aseptically removed and
placed in an eppendorf containing lOOpl of sterile water. The sample was vortexed for
10-15sec. The tube was placed in a thermal cycler (T 3000, Biometra) for 5 minutes at
99‘’C. The sample was then centrifuged for lOmin at 12,000rpm, after which the
supernatant was removed and stored at 4*^0.
•

Determination of DNA concentration

After the extraction of DNA from the bacterial culture it was possible to determine the
concentration and purity of the final extract using a nano drop^'^^ spectrophotometer
(Thermo scientific).

The nano drop was set according to the manufacturer's instructions. Once the system
was operational, 1 pi of sterile water was placed on the sensor to wash the system. This
was repeated a second time to blank the system, after which 1 pi of DNA was placed on
the sensor, and results were recorded.
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2.3.2 PCR Preparation for all 100 NTM isolates
PCR was used to amplify multiple targets from the mycobacterial DNA. The core
composition of the reaction mix was common to all reactions, with minor modifications
required for specific targets as outlined below. All amplifications were carried out in a
final reaction volume of 50pl. Table 2.2 shows the master mix concentration for each
target. Products from Bioline'*'’^ (core kit) were used throughout this study.
5 pi of lOx Reaction Buffer (Bioline)
3pl ofMgCf (25 mM).
1 pi of lOOmM dNTP (25mM each dNTP).
1 pi of forward primer and Ipl of reverse primer (diluted to 20pmol/pl)
0.5pl of Taq DNA polymerase (5U/pl) (BIOLINE).
35.5pl of PCR grade water.
3 pi of template DNA extracted by GITC lysis.
Samples were well mixed before use.
Thermal-cycler T3000 (Bioline)

Target

16S

lOX

25mlVI

lOOmM

Primer

4%

5U/pl

Buffer

MgCh

dNTPs

Mix F/R

DMSO

Taq

5pl

3pl

Ipl

2pl

N/A

DNA

HjO

Total

0.5pl

3pl

3S.Spl

SOpl

.

IS1245

5pl

3|il

Ipl

2pl

N/A

0.5pl

3pl

3S.Spl

SOpl

IS1311

5pl

3|il

Ipl

2pl

N/A

0.5pl

3pl

3S.Spl

SOpl

IS901

5pl

3|il

Ipl

2pl

N/A

O.Spl

3pl

3S.Spl

SOpl

IS900

5|il

3|il

Ipl

2pl

N/A

0.5pl

3pl

3S.Spl

SOpl

5pl

3|il

Ipl

2pl

4pl

O.Spl

3pl

31.Spl

SOpl

5pl

3^1

Ipl

2pl

4pl

O.Spl

3pl

31.Spl

SOpl

5pl

3pl

Ipl

2pl

4pl

O.Spl

3pl

31.Spl

SOpl

hsp65
TBll/12
M\Chsp65
hsp574F
MAChsp65R

Table 2.2 Master Mix volumes for each target
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2.3.3 Primer Sets for identification ofNTMs
Throughout this study several different sets of primers were used. Table 2.3 below gives
the primer name, sequence, size of product and where it was sourced. Once a primer was
chosen it was ordered online from MWG Operon using their Oligo a la Carte option

{www.mwg-biotech.com). Each primer was used in the identification of isolates to either
species level, or in conjunction with sequevar analysis to identity sub-groups of MAC.
-16S (a)
Because of its ability to rapidly identify mycobacteria, all 100 isolates were subjected to
16S rRNA analysis. The master mix composition can be found in Tables 2.2. (a), (b), (c).
Target

Primer Sequence

Size

Reference

16s

5’ GAG AGT TTG ATC CTG GCT CAG 3’ forward
5’ TGC AC A CAG GCC AC A AGG GA 3’
reverse

1059bp

Kirschner et al 1993

-IS elements (b)
IS elements were used as a confirmatory tool for the identification of MAC isolates to a
species level, and also to identity MAC to a subspecies. For example 1S900 can
specifically identify MAP isolates. All 66 MAC isolates were amplified using these
primers, a description for which can be found in section 1.3.5.

Target

1S1245

IS1311

IS900

IS901

Primer Sequence
5’ GCC GCC GAA ACG ATC TAC 3’
forward
5’ AGG TGG CGT CGA GGA AGA 3’
reverse
5’ GCG TGA GGC TCT GTG GTG AA 3’
forward
5’ ATG ACG ACC GCT TGG GAG AC 3’
reverse
5’ CCG CGG AAG GCA AGA CCG 3’
forward
5’ CGA GGA ACT CAG CGC CCA G 3’
reverse
5’ GCG CTG AGT TCC TCG TAA T 3’
forward
5’ CTT CGT CTT GAG GCT GAA 3’
reverse
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Size

Reference

427bp

Alvarez 2008

608bp

Alvarez 2008

574bp

Kunze 1992

577bp

Kunze 1992

-hsp65 (c)
These primers were used in the identification of MAC isolates to a sub-species level.
Once DNA amplified by these primers was sequenced, sequevar analysis could then be
performed on the MAC isolates to identify their sub-groups. All 66 MAC samples in the
bank were identified to a sub-species level using these primers.

Primer Sequence

Target
MAChsp65

hsp-574F
MAChsp65R

hsp65 TB
11/12

5’AAT TGC GTA CGA CGA AGA GG 3’
forward
5’ ACG GAC TCA GAA GTC CAT GC 3’
reverse
5’CGG TTC GAC AAG TAC AT 3’
forward
5’ACG GAC TCA GAA GTC CAT GC 3’
reverse
5’ACC AAC GAT GGT GTG TCC AT 3’
forward

Size

Reference

1621bp

Turenne 2005

1059bp

Turenne 2005

440bp

Turenne 2005

5,

reverse
5' ACG GAC TCA GAA GTC CAT GC 3'
reverse

Table 2.3 (a), (b), (c) Listing targets, sequence, size and reference for all primers.

2.3.4 J6S rRNA gene amplification ofNTM.
As stated above, the 16S rRNA gene was the first target used for molecular
identification to a species level due to the difference in hypervariable regions A and B,
which are amplified by specific primers. The master mix composition and primer
sequence that were used can be found in Tables 2.2 and 2.3. It was necessary to carry
out PCR optimisation before routine analysis. Table 2.4 below shows how optimisation
was carried-out. Figures shown in red were the parameters that were changed for that
run; the final optimised run is emphasised in bold. Each of the other primer sets had
their own optimal thermal cycler settings, and these can be seen in Table 2.5 below.
PCR settings for each primer set were taken from the papers referenced in Table 2.3.
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Initial
Denature

Denature Step

Step

Annealing

Extension

Final Extension

No of

Step

Step

Step

Cycles

Target 16S

Temp

Time

Temp

Time

Temp

Time

Temp

Time

Temp

Time

First Run

94°C

4min

94°C

Imin

60°C

Imin

12°C

Imin

72°C

lOmin

35

94°C

4min

94°C

Imin

58°C

Imin

72°C

Imin

72°C

lOmin

35

94°C

4min

94°C

Imin

530c

Imin

72°C

Imin

72°C

lOmin

35

94°C

Imin

94°C

Imin

53°C

Imin

72°C

Imin

12°C

lOmin

35

94°C

Imin

94X

Imin

55°C

Imin

72°C

Imin

72°C

lOmin

35

940c

4min

94°C

Imin

55°C

Imin

72°C

Imin

72°C

lOmin

35

Second
Run
Third Run
Fourth
Run
Fifth Run
Optimised
Run

Table 2.4 Optimisation of 16S rRNA gene amplification protocol using ThermalCycler T 3000

Initial Denature

Denature

Annealing

Extension

Final Extension

No. of

Step

Step

Step

Step

Step

Cycles

Target

Temp

Time

Temp

Time

Temp

Time

Temp

Time

Temp

Time

IS1245

94°C

Imin

94°C

Imin

65°C

1 min

72°C

Imin

72°C

lOmin

30

IS1311

94°C

2min

94°C

Imin

62°C

15 sec

72°C

Imin

72°C

3 min

37

IS901

94°C

Imin

94°C

Imin

65°C

30sec

72°C

150sec

72°C

5min

30

IS900

94°C

Imin

94°C

Imin

68°C

30sec

72°C

150sec

72°C

5min

30

TBll/12

94°C

3min

94°C

Imin

55°C

Imin

72°C

Imin

72°C

lOmin

45

hsp65

94°C

3 min

94°C

4 5 sec

55°C

45sec

72°C

Imin

72°C

lOmin

35

hsp574

94°C

3min

94X

4 5 sec

55°C

4 5 sec

72°C

Imin

72°C

lOmin

35

Table 2.5 Thermal-Cycler T3000 programmes for each of the Molecular Targets

51

2.3.5 Analysis of DNA using agarose gel electrophoresis
PCR products were visualised by loading them on a gel containing ethidium bromide,
which intercalates between DNA bases, and fluoresces under UV light, using standard
procedure.
• Visualisation of agarose gel
Once electrophoresis was carried out at 1 lOV for 60 minutes, DNA bands were
visualised using a UV light source. A photographic image of the gel was taken using
DNr Bio-imaging system MiniBis™ and printed using the Fujifilm thermal imaging
system FTI-500™
• Purification and sequencing
Before sequencing, PCR products were purified according to directions included in the
Sigma GeneEluteT^*^ clean-up kit, after which 50pl of final purified product was
obtained. In each case this was sent for sequencing analysis to MWG Operon^’^
Germany {www.mwg-hiotech.com). Two 1.5ml eppendorfs each containing 20pl of
sample (one for the forward analysis and one for reverse analysis), along with 2pi of
forward primer and reverse primer (for each sample) were sent to Eurofms Operon
MWG biotech plant in Germany.
• Post-sequencing analysis
After samples were sequenced it was possible to download the results from the MWG
website. Software programmes such as DNA STAR™, a sequencing tool designed as
comprehensive software for DNA and protein sequencing analysis, contig assembly and
sequence project management were used for analysis.
Once the assembly of the 16S rDNA sequences for each isolate was complete,
sequences were then submitted to the BLAST similarity search program of the NCBI
database. For comparison purposes, sequences were also submitted to the RIDOM
similarity search program, which is an alternative for the identification of other known
bacterial species.
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2.3.6 Identifying MAC isolates to sub-species level using sequevar analysis.
This analysis was carried-out according to the method used by Turenne et al (2005). All
66 MAC isolates were amplified using the required primer sets TBl 1/12 (441 bp) and
hsp574 (1059bp) as described in Table 2.2.These were sequenced and results compiled
using DNASTAR ™ (specifically the programme Seqman™). A sequevar code was
established for each of the 66 MAC isolates, based on criteria outlined in a previous
study’^^, allowing each sample to be identified to the sub-species, level of
-

M. avium subsp avium

- M. avium subsp hominissuis

-MAP

-M. avium subsp silvaticum

Figure 2.1 showing alignment of the two primer sets (TBl 1/12 (441 bp), hsp574
(1059bp)) alignment along the MAA104 genome.
SNP along MAA104 genome
SNP
145bp

i

i

SNP
i

5851.P

SlZlT’IJ, m I j

441 bp

IJ, j,J,J,1536bp

y

1059bp

---------------------------------------------------------------------------------------------------------------------------------- >

Hs’p65 1621 bp
rz^

Primer hsp65 TBll/12
Primer hsp65MAC574

Figure 2.1 Primers used in the identification of sequevars
As can be observed from Figure 2.2 using MAA104 as a reference sequence, it is
possible to identify the appropriate sequevars codes (1-14). For example, MAA104 is
sequevar code (1), 76021 has 3 SNPs when compared to MAA104 and is classed as
code (2) etc. This alignment and analysis was carried out for all MAC isolates in the
bank in order to assign a sequevar code.
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Figure 2.2 SNP among MAC strains for sequevar analysis 125
The sequevar codes are represented down the left-hand side of this image, MAA104 is
code 1, 76021 is code 2. The specific nucleotide position used to differentiate between
the sequevar codes are listed in the base pairs along the top (240bp - 1536bp). Each
code is then associated with a subspecies of MAC, for example codes 1 and 2 were
identified by Turenne as M avium subsp hominissuis
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2.4 ENVIRONMENTAL ANALYSIS OF NTM.
In addition to the molecular analysis and identification of isolates from a clinical
setting, a second study was undertaken to determine the prevalence of mycobacteria in
the environment. This study specifically looked for the presence of mycobacteria in a
selection of water samples. It was decided to take samples from a variety of sources
(see below), over several months, specifically in the Cork City and County area. The
objective was to compare mycobacteria isolated directly from the environment, with
mycobacteria isolated from patients in hospitals. Before this comparison could be
undertaken, a series of optimisation steps had to be performed for the environmental
samples including:
1. Determining appropriate sample sources.
2. Choosing a sample collection technique.
3. Optimizing decontamination of water to eradicate contaminating species
4. Culturing and propagation of samples.
5. DNA extraction from suspect isolates / direct from water samples.
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6. Identifying isolates (16S typing / sequencing).
2.4.1. Collection of Water Samples.

It was decided that 70 water samples would be collected for this study, from a variety of
sources including (Table 2.6 below):

Rivers^

Streams

Lakes

33

9

14

1

Ponds

Well

Treated water
systems.

Milking
Parlour

1

1

11

1

Table 2.6 List of different water sources, and no. of samples collected from each
source
Samples were collected between January '09 and May '09, and data was collected for
each of the samples under the headings outlined in Table 2.7 below. 1.5 litres of water
was collected from each sample point in sterile screwcap bottles. Samples were kept
cool (4‘^C) and processed within 5 days of collection. Maps showing exact collection
sites for each sample can be found in the appendix section (page 115).

Sample
No

Location of
sample

„
^

Volume

Source

Media

Decontamination
method

Area

Table 2.7 A Sample of the recorded data headings for the environmental samples
Before samples were processed it was necessary to ensure that the optimum
decontamination methods were used, as both the RGM and SGM could be outgrown by
other bacterial contaminants present in the water samples. A test was employed to
evaluate the decontamination methods on known amounts of bacteria.

^All isolates were referenced on a map of Cork on page 115
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2.4.2 Colony counts
Colony counts were carried-out on spiked water to establish the quantity of
mycobacteria in one litre of water, pre-decontamination and post-decontamination.
Results from pre and post decontamination were compared, and the percentage loss
calculated. The procedures are outlined m section 2.4.3.
2.4.3. Optimisation of Cetylpyridinium chloride monohydrate (CPC) decontamination:
Once the number of viable mycobacteria was determined, the number of survivors
following decontamination could be established, as outlined below
Method:
1.

lOmls of M. smegmatis culture was placed in 4 separate Duran bottles
containing IL of sterile distilled water, along with a magnetic stirrer. 1ml of
sample was aseptically removed from each bottle and viable numbers of
mycobacteria were determined using colony counts, following appropriate
serial dilution (lO"^).

2. Decontamination of water using 4 different concentrations of CPC was then
carried out as follows:
3. Using an automated pump, in each case one litre of sample was filtered
through a 0.45pm filter. The filter was aseptically placed in a sterile 50ml
falcon tube containing lOmls of original water sample, and vortexed for 5
minutes.
4. Samples were de-contaminated with different concentrations of CPC
(0.01%, 0.005%, 0.003% and 0.001%) to determine optimum concentration
and time (refer to Table 2.8).
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Concentration of CPC (final concentration)
0.010%

0.005%

0.003%

0.001%

5min

5min

5min

5min

lOmin

lOmin

lOmin

lOmin

15min

15min

15min

15min

20min

20min

20min

20min

25min

25min

25min

25min

Table 2.8 Showing varying time and concentration combinations for
CPC decontamination
5. For each concentration 100|al of decontaminated water was aseptically
removed after 5min to a sterile eppendorf A serial dilution was carried out
and the number of mycobacterial survivors was calculated following plating
and incubation. This was repeated at lOmin, 15min, 20min and 25min for
each concentration.
6. Results were then compared to the pre decontamination sample; in order to
calculate the percentage survivors.
Decontamination using CPC on water samples

1. Following optimisation, all 70 water samples were treated with 0.001% CPC
for 5 minutes at room temperature, with slight modifications as outlined
below.
2. After decontamination the concentrated lOmls was centrifuged for 20
minutes at 3,000rpm. The supernatant was poured off and the pellets were
rinsed with 1ml of PBS, before being centrifuged again. Pellets were re
suspended in 1ml of sterile water.
3. Once pellets were re-suspended, 0.5mls of the sample was spread plated
onto Middlebrook agar plates with supplement, and the other 0.5mls was
spread onto Middlebrook slopes with supplement.
4. Plates were incubated for 8-10 weeks, and checked twice weekly for suspect
colonies.
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2.3.4 Optimisation of NaOH decontamination
1. A similar strategy was used for the optimisation of NaOH decontamination.
2. 50mls of water sample was placed in a sterile 50ml falcon tube as per^.The
sample was centrifuged at 4,000rpm for 10 minutes to form a pellet.
3. The supernatant was removed and the pellet was re-suspended in 400pl of
sterile water and de-contaminated.
4. Decontamination of water using 4 different concentrations of NaOH was then
carried out as follows. Samples were de-contaminated with different
concentrations of NaOH (1.0%, 0.60 %, 0.30% and 0.01%) to determine
optimum concentration and time (refer to Table 2.9).
Concentration of NaOH (final concentration)
1.0%
5min
lOmin
15min
20min
25min

0.60%

0.30%
5min
lOmin
15min
20min
25min

5min
lOmin
15min
20min
25min

0.01%
5min
lOmin
15min
20min
25min

Table 2.9 Showing varying time and concentration combinations for
NaOH decontamination
5. A neutralisation step was carried-out by adding 12pi of glacial acetic acid, for
each concentration. lOOpl of decontaminated water sample was aseptically
removed after 5 minutes to a sterile eppendorf A serial dilution was carried out
and the number of mycobacterial survivors was calculated following plating and
incubation. This was repeated at lOmin, 15min, 20min and 25min for each
concentration.
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•

Decontamination using NaOH on water samples
1. Following optimisation, all 70 water samples were de-contaminated using
0.6 % NaOH for 10 minutes at room temperature, with slight modifications,
as outlined below:
2. After 10 minutes a neutralisation step was carried out by adding 12pl of
glacial acetic acid, the entire mixture was then plated onto MB agar and
incubated at 37*^0 for 8-10 weeks.
3. This method was carried out twice on each sample, so that samples could be
plated onto Middlebrook agar (with added supplement) and Middlebrook
slopes (with added supplement).These samples were also examined twice
weekly for suspect colonies.

2.4.5 Cultivation ofEnvironmental isolates.
• Propagation
Once the decontamination procedures were performed on the samples, it was then
necessary for them to be purified and analysed. Samples were divided between the
plates and slopes to see if a difference could be observed such as colony growth rate,
colony morphology and contamination. Figure 2.3 summarises the process of water
sampling, from sample collection to incubation.
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-►

1 ml of water was
removed from
10ml concentrate
for DNA
extraction

Sample Collection
ILitre & 50mls
•

Rivers, Lakes, Streams,
Wells.

Sample Vol: lOOOmls.

Sample Vol: 50mls.

-Concentration; Filtration and
DNA extraction.

Concentration; Centrifugation
and DNA extraction.

Decontamination: CPC.

Decontamination: NaOH.
Time; 5 min

agar and

Slope in
20mls MB
agar and

15mlsMB

Cone; 6%

Standard
agar plate,
15mlsMB

Figure 2.3 summarises the process of water sampling, from sample collection to
incubation
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•

Observation

When colonies began appearing on the plates they were removed aseptically, and
placed both in an eppendorf containing lOOul of sterile water, for DNA extraction and
streaked onto fresh agar plates to obtain pure isolates. Samples were also examined
using the ZN stain, as outlined in section 2.2.1. These were the first steps in identifying
an isolate.
•

DNA extraction and PCR confirmation

As mentioned above, once a suspected colony was cultured sufficiently to obtain
enough biomass, it was placed aseptically in lOOpl of sterile water. DNA was extracted
by boiling or GITC lysis, which was carried-out according to the procedure outlined in
section 2.3.1. PCR was then carried-out using 16S primers, and master mix volumes
from Table 2.2, and the Thermal-Cycler programme shown in Table 2.3. Amplified
DNA from these isolates was then sent to MWG for sequencing.
2.4.6 Positive environmental isolates.
Once a positive isolate was identified post-sequencing using an online system such as
BLAST/RIDOM, then it was necessary to ensure that a pure colony was available for
stocking. Re-streaking of isolates was carried-out several times to obtain a pure colony.
Colonies were then stocked at -20‘^C and -80‘^C.
2.6.7 Culture independent DNA extraction from water samples
As well as using DNA extraction / PCR as a means of identifying isolated colonies
these techniques were also employed to screen the original water samples for the
presence of mycobacteria in the absence of culturing; see Figure 2.3.
This method was also evaluated during the study. Since the cultivation time for growing
of mycobacteria colonies was considerably long, 50 of the 70 samples were tested using
this method as follows. Before the addition of CPC, 1 ml of water was removed. From
this, DNA was extracted directly from the water using the following procedure.
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Method:
1. The eppendorf was centrifuged for 5 minutes at 12,000rpm. Once completed,
the supernatant was poured off leaving the pellet at the bottom of the eppendorf
Steps 3-9 were followed as per section 2.3.2.
2. Master Mix was prepared as outlined in section 2.3.3, using 16S primers and
optimised Thermal-Cycler programme outlined in Table 2.4.
3. Products were run on 1.5% agarose gel at 90V for 60min and visualised under
UV light.
4. Positive bands were sent for sequencing analysis to MWG.
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Chapter III
Results
Clinical Isolates^

Originally 71 MAC isolates were collected; over the course of this study 5 M>ere re-typed
and re-classified. Consequently the final number ofMAC isolates became (n-^66) (Cork
n=2(), Dublin n~46).
"
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3.1 COLLECTION AND CULTIVATION OF ISOLATES
3.1.1 Bacterial strains.
In this study 100 mycobacteria isolates were cultured from patients admitted to
C.U.H. and St James' Hospital, Dublin. Initially, all isolates were identified to a
species level on the basis of biochemical and molecular assays carried-out in Cork
and Dublin respectively. C.U.H, also provided a data sheet containing information
regarding patient's age, sex, site of infection, and other clinically relevant information.
The full datasheet related to the Cork isolates can be seen below in Table 3.1.

Isolate

Isolation
date

Site of
infection

Sex D.O.B

M. abscessus 05/14

20/07/2005

Respiratory

M

1931

M. abscessus 05/15

15/09/2005

Respiratory

M

1989

75
17b

M. abscessus 06/21

08/11/2005

Respiratory

M

1989

17^

M. abscessus 06/24

N/A

N/A

N/A

N/A

N/A

M. chelonae 05/04

02/02/2005

Respiratory

M

1948

58

M. chelonae OSHO

N/A

N/A

N/A

N/A

N/A

M. chelonae 05/21

23/11/2005

Orbital implant

M

1944

62

M. chelonae 06/01

07/03/2006

Respiratory

M

1948

58

M. chelonae 06/07

15/05/2006

Respiratory

F

1981

25

M. chelonae 06/10

25/05/2006

Respiratory

M

1948

58

M, chelonae 06/14

17/07/2006

Blood Orbital

M

1973

33

M. chelonae 06/22

09/11/2006

Respiratory

1948

58 ‘

M. fortutium 06/09

26/06/2006

Respiratory

M

1931

75

M. gordonae 05/01

12/01/2005

Respiratory

M

1938

68

M. gordonae 05/0^

23/03/2005

Respiratory

M

1943

63

M. gordonae 06/15

16/08/2006

Respiratory

M

1919

87

M. kansasii 05/22

N/A

N/A

N/A

N/A

N/A

M. kansasii 06/11

29/06/2006

Respiratory

M

1945

61

M. kansasii 06/25

N/A

N/A

N/A

N/A

N/A

M. kansasii 07/01

23/01/2006

Respiratory

M

1945

61

MAC 05/02

27/01/2005

Respiratory

M

1945

61

^Isolates were extractedfrom the same patient, a cystic fibrosis suffer.
Isolates were extractedfrom the same patient.
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Age

Isolate

Isolation
Site of infection Sex D.O.B
date

Age

MAC 05/03

27/01/2005

Respiratory

F

1930

76

MAC 05/06

09/03/2005

Respiratory

F

1934

72

MAC 05/09

15/04/2005

Respiratory

F

1953

53

MAC05/H

12/05/2005

Respiratory

F

1923

83

MAC05/13

20/06/2005

Respiratory

M

1969

37

MAC05/16

15/09/2005

Respiratory

M

1930

76

MAC05/18

05/10/2005

Respiratory

F

1976

30

MAC05/20

14/11/2005

Respiratory

F

1936

70

MAC06/02

20/02/2006

Respiratory

F

1950

56

MAC06/03

20/02/2006

Respiratory

M

1941

65

MAC06/05

02/03/2006

Respiratory

F

1934

72

MAC06/06

10/03/2006

Neck Abscess

F

1999

7

MAC06/08

13/04/2006

Respiratory

M

1975

31

MAC06/13

07/07/2006

Respiratory

F

1934

72

MAC06/16

09/08/2006

Pancreatic cyst

M

1956

50

MAC06/18

28/06/2005

Respiratory

F

1932

74

MAC06/19

16/08/2006

Respiratory

M

1921

85

MAC06/20

29/09/2006

Respiratory

M

1933

73

MAC06/23

16/11/2006

Respiratory

F

1920

86

MAC06/26

19/02/2007

Respiratory

M

1960

46

M. malmoense 05/07

23/03/2005

Respiratory

F

1948

58

M. malmoense 06/12

31/07/2006

Lymph node

F

2001

5

M.terrae 05/05

09/03/2005

Respiratory

M

1935

71

M.terrae 05/23

15/06/2005

Elbow Bursa

M

1975

31

M.terrae 05/23

22/12/2005

Respiratory

M

1933

73

M.terrae 06/17

19/10/2006

Tissue Leg

F

1939

67

M. xenopi 05/17

10/10/2005

Respiratory

F

1918

88

M. xenopi 05/19

18/10/2005

Respiratory

M

1936

70

M. xenopi 06/04

22/05/2006

Respiratory

M

1929

77

Table 3.1 Data sheet provided by C.U.H outlining patient data

With the patient data obtained from the C.U.H. it was possible to carry-out a broad
epidemiological analysis of the information. From the data, a series of charts was
compiled including, the number of isolates recorded each month over the two years
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(Figure 3.1), age distribution (Figure 3.2), gender ratio and sites of infection (Figure
3.3 (a) and (b)).

Seasonality
4.5
3.5
2

2.5
B2005

I

0.5

^

SO

^

^
^

^

H2006

^

^ ^
<r O ^ <cF<5^

Months

Figure 3.1 Number of isolates cultured each month Jan-2005 to Dec-2006

Age distribution
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Age (years)

Figure 3.2 Age distribution profile of patients from the C.U.H cohort
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(b)

(a)

Profile for NTM isolates (CUH)
B Rcspirotory
B Neck Abscess

BPjncrealiccysl
BOrbitiolinplant
B Elbow Bursa
B Tissue Leg
u Lymph Node
B Blood Culture

Figure 3.3 (a) Gender ratio for NTM infection (Left)
3.3 (b) Profile for NTM isolates (Right)

On average only 2-3 isolates, were obtained each month throughout the two-year
period. Unsurprisingly, 78% of all individuals infected by NTM were over the age of
50, while 28% of patients fell specifically within the 71 - 80 age-brackets. As
mentioned, the age profile of the entire patient cohort was older. The highest numbers
of infected patients were found between 71-80 years, while the fewest isolated were
recovered from those aged 21 - 30. Also it was determined that the most frequently
reported site of infection was overwhelmingly respiratory origin at 85%. Finally,
NTM infections in Cork were more prevalent in males (62%) as opposed to females
(38%).

Further analysis of the Cork isolates revealed that 21 isolates were classified as MAC.
Within this sub-set it was determined that 95% of the isolates were derived from
respiratory infections, which is generally considered the most common site of
infection for MAC. Also, 90% of infections occurred in the over 50 age-group, with
70% falling within the 71 - 80 age category. Finally, in terms of susceptibility there
was a more even distribution with MAC infecting 50% of males and 50% of females.

St James' Flospital Dublin was unable to provide this study with epidemiological
information on the isolates which they donated. A data sheet was given showing the
number of MAC isolates collected over a 7-year period. Isolates used in this study
were recovered from patients between 2005 and 2007 (Figure 3.4).
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Figure 3.4 Incidence of MAC infections for St James’ Hospital 2000-2007''

The highest incidence of MAC infections identified by St James' Hospital occurred
during 2006 (n=22), and the lowest occurred in 2000 (n=5); On average 37 MAC
isolates were collected each year from this hospital over the seven years. After
compiling the clinical data from the patients, attention was then turned to culturing
and propagating all 100 isolates from both sources with a view to characterising and
profiling them.

3.1.2 Cultivation and propagation:

All of the 100 mycobacterial isolates from both Cork (n=50) and Dublin (n=50) were
successfully propagated on Middlebrook agar and in Middlebrook broth over the
course of 18 months. Initial cultivation times for each species took considerably
longer than later sub-cultures. It was found that each of the mycobacterial species in
the bank generated by C.I.T. had different growth rates, which are outlined in Table
3.2. Morphology differed for each of the species, many appeared rough with slightly
raised colonies and were cream in colour, while some were pigmented a (bright
yellow) with smooth colonies. An outline of the morphology for all 100 Cork and
Dublin isolates can also be seen in Table 3.2.

Isolates used in this study were taken from patients betM’een 2005 and 2007.
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Subsequent
Initial
Initial species
N= cultivation cultivation
Classification
time
Time
M. abscessus

M. chelonae

M. fortutium

M. gordonae

4

8

1

3

7-10 days

7-10 days

7-10 days

10-14 days

Morphology

Growth
rate

4-6 days

Smooth or Rough,
Cream / greyish
colonies.
Nonphotochromogenic**

RGM

4-6 days

Shiny or Rough, Cream/
buff colonies.
Nonchromogenic.

RGM

4-6 days

Smooth colonies off
white/ cream colour.
Nonchromogenic.

RGM

5-7 days

Smooth and yellow or
orange colonies
Scotochromogenic.

SGM

SGM

M, kansasii

4

10-14 days

7-10 days

Colonies are brown in
colour when grown in
darkness, becoming
bright yellow when
exposed to light.

M. malntoense

2

4-6 weeks

14-21 days

Smooth nonpigmented
colonies.

SGM

SGM

M. terrae

4

4-6 weeks

10-14 days

Pale buff to yellowishbrown, pale leather
coloured colonies.
Nonphotochromogenic.

M. xenopi

3

4-6 weeks

10-14 days

Smooth nonpigmented
colonies, on ageing most
colonies became yellow.

SGM

MAC

71

3-4 weeks

10 - 14 days

Smooth but occasionally
rough, on ageing, some
colonies became yellow.

SGM

Table 3.2 Study of growth rates and morphology for each mycobacterial species

^ Reference page 4, morphology based on Runyon's classification.
^ Later on in this study 4 of the Dublin isolates were reclassified by St James' Hospital as M.
celatum (3) and M. shimoidei (I), while one Cork MAC isolate was identified as M.
lentijlavum after 16S rRNA typing.
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3.2 MICROSCOPIC IDENTIFICATION OF ALL NTM.
3.2.1 Ziehl-Neelsen Stain.
As referenced earlier in section 1.3.1, the ZN stain may be used as a rapid
identification tool for detecting the presence of mycobacteria directly from a clinical
sample e.g. sputum. All 100 isolates in this study were stained using the ZN method,
which confirmed the presence of mycobacteria and the absence of contamination.
Both hot and cold staining methods were used as outlined previously. All 50 Cork
isolates were stained using the hot method (section 2.2.1), while the 50 Dublin
isolates were stained by the cold method. Differentiation between the two methods
was minimal, although the cold method was deemed easier to perform. Figures 3.5 (a)
is a sample of M smegmatis stained by the hot method, and (b) a sample of MAC
stained using the cold method. M .smegmatis was not part of the clinical bank, but
was used as a lab model strain for routine optimisation experiments. Each species of
mycobacteria varied slightly when observed under the microscope. Most species such
as M smegmatis and M. gordonae (see Figure 3.5(b)) appeared as long slender rods,
with a typical Chinese lettering style in appearance. Other species such as MAC and
M chelonae were shorter and had a more round like appearance. The phase of growth
and age of the culture also influenced the quality of the stain.
Shorter rods,
Chinese-style
lettering

Slender rod,
Chinese-style
lettering.

it

P

A7

Figure 3.5 (a) ZN strain on M. smegmatis hot method (left)
3.5 (b) ZN stain on M gordonae cold method (right)
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3.3 MOLECULAR ANALYSIS OF ALL NTM.
3.3.1 DNA Extraction from all 100 NTM isolates.
One of the first steps required for any molecular analysis is the adequate extraction of
DNA from a sample. The extracted DNA should be of reasonably high quality and
yield. Extraction methods ideally should be rapid, reproducible and universal. This
study used two different methods for the extraction of DNA, boiling and GITC lysis.
Boiling produced large quantities of DNA post extraction, however the purity and
quality of the DNA was relatively poor. PCRs carried out using DNA extracted by
boiling produced strong bands, but contained a lot of non-specific bands and
smearing. Figure 3.6 (a) provides a representative sample of a PCR following the
boiling extraction process.
The second extraction procedure used throughout this study on all 100 isolates was
the GITC lysis method. This method took longer but produced cleaner bands that
could be used for sequencing analysis; a sample of this method is represented in
Figure 3.6 (b).
M

1

2

3

4

M N

2

3

4

5

1059bp

Figure 3.6 (a) & 3.6 (b) 1.5% agarose gel showing amplified PCR products after
DNA extraction by boiling and GITC lysis from various mycobacteria using 16S
rRNA primers amplifying 1059bp
Figure 3.6(a) boiling (Left)
Figure 3.6(b). GITC lysis (Right)
Lane M; Molecular weight marker II

Lane M; Molecular weight marker I
1. Mycobacterium ahscessus

1. N: negative control

2. Mycobacterium chelonae

2. Mycobacterium abscessus.

3. Mycobacterium gordonae

3. Mycobacterium chelonae.

4. Mycobacterium fortutium

4. Mycobacterium gordonae.
yi

5. Mycobacterium fortutium.
6. Mycobacterium kansasii.

5. Mycobacterium kansasii
It was determined that extraction by boiling was a good confirmatory tool for rapid
identification of mycobacteria. However, for molecular analysis the GITC lysis
method was deemed the superior method, due to the ability to produce cleaner bands
suitable for sequencing analysis.
3.3.2 Determination of DMA concentration.
Each DNA sample was tested in triplicate using the nano drop spectrophotometer to
generate average concentration values. The main objective of this was to ensure that
each DNA sample was adjusted to 50ng/|il prior to PCR amplification so that
consistently high quality bands would be produced. A summary excel sheet with
average concentration and purity values was produced, a sample of which for each
species can be seen in Table 3.3 below.

Table of average results from nano drop
Sample ID

Date

Average ng/pl

M. ahscessus 05/14
M. chelonae 05/04
M. fortutium 06/09
M. gordonae 05/01
M. kansasii 05/22
MAC 05/02
M. malmoense 05/07
M. terrae 05/05
M. xenopi 05/17

22/05/2008
22/05/2008
22/05/2008
22/05/2008
22/05/2008
22/05/2008
22/05/2008
22/05/2008
22/05/2008

1881.83
2682.08
1798.87
2961.89
1325.56
3331.67
4616.55
5200.43
1295.09

Protein Purity
260/280
1.9
1.9
1.73
1.83
1.7
1.98
2
1.82
1.7

Table 3.3: A representation of the excel sheet generated by results obtained from
the Nano Drop for 9 species of mycobacteria

• PCR
A series of PCR targets was amplified from the bank in an effort to produce a
comprehensive molecular profile. The first target chosen was the 16S rRNA gene.
This has been regarded as the gold standard for the identification of mycobacteria
(refer to section 3.4) using molecular analysis. This study compared the results for all
100 isolates that were determined by biochemical analysis in the respective hospitals.
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against 16S rRNA typing used in this laboratory. This was the first time molecular
profiling was performed on a group of NTM isolates in Ireland.
3.3.3 16S rRNA gene amplification.
The extracted DNA templates from all 100 mycobacterial isolates (Cork and Dublin),
were subjected to DNA amplification with 16s rRNA universal primers listed in Table
2.3. Once amplification was complete, the PCR products were resolved by a 1.5%
agarose gel electrophoresis. A 1059bp band present on the gel confirmed successful
PCR amplification. Successful PCRs were carried-out on all 100 isolates investigated
in this study. Figures 3.7 and 3.8 show results for a representation of isolates
amplified using 16S rRNA primers from both Cork and Dublin.

M

N

10

1059bp

Figure 3.7 Results of the 16S rRNA gene amplification for 10 representative
Mycobacterium isolates from the Cork samples. Lane M, contains molecular weight
marker II, N is the negative control. Lanes 1 through 10 contain mycobacterial
isolates from Cork. M ahscessus 05/14, M. terrae 05/12, M. ahscessus 06 24, M.
chelonae 05/04, M. gordonae 05 01, M. chelonae 05/21, M. chelonae 06 01, M.
chelonae 06 07, M. kansasii 07/01, MAC 05/20.
M 1 2

3

4 5 6

7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 N

1059bp

Figure 3.8 Results of the 16S rRNA gene amplification for 23 representative
MAC isolates from the Dublin samples. Lane M molecular marker II, N negative
control. Lanes 1 to 23 mycobacterial isolates from Dublin: MAC 49, MAC 43, MAC
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47, MAC 56, MAC 67, MAC 41, MAC 30, MAC 50, MAC 31, MAC 38, MAC 40, MAC
32, MAC 60, MAC 61, MAC 21, MAC 83, MAC 23, MAC 48, MAC 22, MAC 63. MAC
01, MAC 02, MAC 03.

• Purification of PCR products after 16S rRNA gene amplification.
For all 100 isolates, the 16S rRNA gene product was cleaned and sent for sequencing,
as outlined on page 52.
3.3.4 Sequencing ofPCR products

DNA sequencing was performed on all 100 16S rRNA gene products that had been
amplified, at the DNA Core Sequencing Facility, MWG- Operon Germany. Results
were posted on the MWG website and could be downloaded in a zip file for further
analysis. Figure 3.9 is a representation of a chromatogram of a DNA sequence from
one of the Cork isolates.
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Figure 3.9 Representative chromatogram of DNA sequence received from MWG
post PCR and sequencing
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• Identification of 16S rRNA PCR products
Each DNA sequence was pasted into the DNASTAR™ programme as outlined on
page 52, after which Seqman Pro™ was used to further process the data.

Once the assembly of the 16S rDNA sequences for each isolate was complete,
sequences were then submitted to the BLAST similarity search program of the NCBI
database.

• BLAST VRIDOM
Both BLAST and RIDOM gave identical species results for each of the isolates
sequenced, the results of which can be seen in Tables 3.4 and 3.5, indicating that both
databases are able to rapidly and accurately identify mycobacteria to a species level.

• Cork
Using 16S analysis, 3 Cork strains were shown to have been originally mis-identified
at the species level. The 3 in question were M kansasii 05/22, and MAC 06/13 which
were identified as M lentiflavum, while M xenopi 06/04 was identified as M
nonchromogenicum (see Table 3.4). This represented a 6% difference between Cork
Hospital results and our molecular results. A phylogentic tree was created to visualise
the relationship between the three different strains to their original identification
(Figure 3.10).

In summary, 16s profiling of the Cork bank was in agreement with the traditional
initial identification methods used in 94% of cases. Although it is more accurate and
potentially faster than methods currently in-place, it requires specialised expertise and
extra laboratory resources. Its routine implementation in the Cork mycobacterial
laboratory may not be justified in isolation due to the relatively low throughput of
NTM per year, but if adopted as a method for all clinical isolates including TB and
other noteworthy pathogens, it may prove advantageous.
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• Dublin
The entire Dublin bank consisted of 50 isolates which were all initially classified as
MAC based on routine laboratory identification at the host laboratory. Subsequent
sequencing analysis in our laboratory using IbsrRNA typing identified 4 of the
Dublin isolates as M. intracellulare. Even though M intracellulare is not directly
classed as a sub-species of MAC, it is part of the MAI group which is very closely
related to MAC, and many profiling methods will not distinguish between both
groups. Following analysis, all other 42 Dublin isolates, including the three M
celatum and the single M shimoidei, were recorded exactly as originally identified by
the Hospital to the species level (Table 3.5).

It should also be noted that the 16S sequencing results were unable to distinguish
between sub-species of the MAC isolates when examined using both BLAST and
RIDOM. For consistency in the tables, all MAC isolates are listed as M avium ssp
avium even though the sequencing score gave an equal identity % value in the output
results to the other 3 sub species of the MAC, namely; M paratuherculosis, M.
hominissuis and M. silvaticum. This was not unexpected, as 16s typing is commonly
regarded as being unable to distinguish between these 4 sub-species. Consequently, it
was decided to generate more in depth profiling of the MAC cohort from both the
Dublin and Cork banks (n=66).
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Figure 3.10 Phylogentic tree showing relationship of NTM species, to determine
the relationship of identified species against other strains of mycobacteria
(Adapted from Tortoli 2003*^*) ^
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Samples MAC 06 03 and M. kansasii 06/22 were identified as M. lentiflavum:isolates are highlighted in red to show phylogentic relationship.
Sample M. xenopi 06 04 was identified as M nonchromogenicumi-isolates are
highlighted in blue to show phylogentic relationship.
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Initial hospital
identity

Identification of Clinical Isolates based on 16S rRNA
analysis

Cork Isolates

BLAST

RIDOM

M. ahscessus 05/14

M abscessus [44196 DSMJ

M. abscessus strain KCl

M. abscessus 05/15

M abscessus [44196 DSMJ

M. abscessus strain KCl

M. ahscessus 06/21

M. abscessus [44196 DSMJ

M. abscessus strain KCl

M. abscessus 06/24

M. abscessus [44196 DSMJ

M. abscessus strain KCl

M. chelonae 05/04

M chelonae [43804 DSMJ

M. chelonae strain ATCC 19237

M. chelonae 05/10

M. chelonae [43804 DSM]

M. chelonae strain HUl 16S

M. chelonae 05/21

M. chelonae [43804 DSM]

M. chelonae strain ATCC 19237

M. chelonae 06/01

M. chelonae [43804 DSM]

M. chelonae strain ATCC 19237

M. chelonae 06/07

M. chelonae ]43804 DSM]

M. chelonae strain ATCC 19237

M. chelonae 06/10

M. chelonae [43804 DSM]

M. chelonae strain ATCC 19237

M. chelonae 06/14

M. chelonae ]43804 DSM]

M. chelonae strain ATCC 19237

M. chelonae 06/22

M. chelonae [43804 DSM]

M. chelonae strain ATCC 19237

M. fortutium 06/09

M. fortutium [44220 DSM]

M. fortutium strain ATCC 49403

M. gordonae 05/01

M. gordonae [44160 DSM]

M. gordonae partial 16S rRNA gene,

M. gordonae 05/08

M. gordonae [44160 DSM]

M. gordonae partial 16S rRNA gene,

M. gordonae 05/15

M, gordonae J44160 DSM]

M. gordonae partial 16S rRNA gene,

M. kansasii 07/01

M. kansasii [44162 DSM[

M. kansasii 16S rRNA gene

M. kansasii 06/11

M. kansasii [44162 DSM]

M. kansasii 16S rRNA gene

M. kansasii 06/15

M. kansasii [44162 DSM]

M. kansasii 16S rRNA gene

M. kansasii 06/22

M. lentijlavum [44418 DSM]

M. lentiflavum strain GR-2466

MAC 05/02

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 05/03

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 05/06

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 05/09

M. avium avium [44156 DSM]

M. avium subsp. avium strain A TCC 25291

MAC 05/11

M. avium avium J44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 05/13

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 05/16

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 05/18

M. avium avium J44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 05/20

M. avium avium [44156 DSM]

M. avium subsp. avium strain A TCC 25291

MAC 06/02

M. avium avium J44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 06/03

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 06/05

M. avium avium [44156 DSM]

M. avium complex strain 64

MAC 06/06

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 06/08

M. avium avium J44156 DSM]

M. avium subsp. avium strain ATCC 25291

MAC 06/13

M. lentiflavum [44418 DSM]

M. lentiflavum strain GR-2466

MAC 06/16

M. avium avium [44156 DSM]

M. avium subsp. avium strain ATCC 25291
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Cork Isolates

BLAST

RIDOM

MAC 06/18

M. avium avium [44156 DSMJ

M. avium subsp. avium strain ATCC 25291

MAC 06/19

M. avium avium [44156 DSM[

M. avium subsp. avium strain ATCC 25291

MAC 06/23

M. avium avium [44156 DSMJ

M. avium subsp. avium strain ATCC 25291

MAC 06/26

M. avium avium [44156 DSMJ

M. avium subsp. avium strain ATCC 25291

M. malntoense 05/07

M. malntoense [44163 DSMJ

M. malntoense 16S rRNA gene

M. malntoense 06/12

M. malntoense [44163 DSMJ

M. malmoense 16S rRNA gene

M. terrae 06/17

M. terrae [S281

M. terrae strain ATCC 15755

M. terrae 05/05

M. terrae [S281

M. terrae strain ATCC 15755

M. terrae 05/23

M. terrae [S281

M. terrae strain ATCC 15755

M. terrae 06/12

M. terrae [S281

M. terrae strain ATCC 15755

M. xenopi 05/17

M. xenopi [43995 DSMJ

M. xenopi [43995 DSMJ

M. xenopi 05/19

M. xenopi [43995 DSMJ
M. nonchromogenicum[44164
DSMJ

M. xenopi [43995 DSMJ

M. xenopi 06/04

M. nonchrontogenicunt J44164 DSMJ

Table 3.4 Showing 16S rRNA gene identification of Cork isolates using both
BLAST and RIDOM online databases

Initial hospital

identification of Clinical Isolates based on 16S rRNA analysis
identity

Dublin Isolates

BLAST

RIDOM

MAC 1

M. avium sub.sp. avium strain ATCC 25291

M. avium, .subsp avium DSM 44156

MAC 2

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44133

MAC 3

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44133

MAC 4

M. avium subsp. avium strain ATCC 25291

M. intracellulare ATCC 13950

MACS

M. intracellulare strain W239

M. intracellulare ATCC 13950

6*

M. celatum 16S rRNA gene

M. celatum DSM 44243

M. celatum 7*

M. celatum 16S rRNA gene

M. celatum DSM 44243

MAC 9

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44133

MAC 11

M. avium subsp. avium strain A TCC 25291

M. avium subsp. avium DSM 44133

MAC 12

M. avium .subsp. avium strain A TCC 25291

M. avium subsp. avium DSM 44133

M. celatum
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Dublin Isolates

BLAST

RIDOM

MAC 13

M. avium subsp. avium strain ATCC 25291

M avium subsp. avium DSM 44133

MAC 14

M. avium suhsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44133

MAC 15

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 18

M.avium subsp. avium strain ATCC 25291

M .avium subsp. avium DSM 44156

MAC 19

M .avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 21

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 22

M.avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 23

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 24

M. avium subsp. avium strain A TCC 25291

M. avium subsp. avium DSM 44156

MAC 25

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 26

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 29

M avium subsp. avium strain A TCC 25291

M. avium subsp. avium DSM 44156

MAC 28

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 30

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 31

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 32

M. avium sub.sp. avium strain DSM 44156

M. avium subsp. avium DSM 44156

M. shintoidei 34*

M. shimoidei 16S rRNA gene

M. shimoidei DSM 44152

MAC 35

M. avium subsp. avium strain ATCC 25291

M .avium subsp. avium DSM 44156

MAC 37

M. avium subsp. avium strain ATCC 25291

M. avium subsp. avium DSM 44156

MAC 36

M. avium subsp. avium A TCC 25291

M. avium subsp. avium ATCC 25291

MAC 38

M. intracellulare ATCC 12950

M. intracellulare DSM 43223

MAC 39

M. avium subsp. avium A TCC 25291

M. avium subsp. avium DSM 44156

MAC 40

M. avium subsp. avium ATCC 25291

M. avium subsp. avium DSM 44156

MAC 41

M. intracellulare ATCC 13950

M. intracellulare ATCC 35772

MAC 42

M. avium subsp. avium ATCC 25291

M. avium subsp. avium DSM 44156

MAC 43

M.avium subsp. avium ATCC 25291

M. avium subsp. avium DSM 44156

80

Dublin Isolates

BLAST

RIDOM

MAC 44

M.avium subsp. avium ATCC 25291

M.avium subsp. avium DSM 44156

MAC 47

M.avium subsp. avium ATCC 25291

M.avium subsp. avium ATCC 25291

MAC 49

M.avium subsp. avium ATCC 25291

M.avium subsp. avium ATCC 25291

MAC 50

M.avium subsp. avium ATCC 25291

M.avium subsp. avium DSM 44156

MAC 53

M.avium subsp. avium ATCC 25291

M.avium subsp. avium DSM 44156

MAC 56

M.intracellulare ATCC 13950

M. intracellulare DSM 42223

MAC 59

M.avium subsp. avium ATCC 25291

M.avium sub.sp. avium DSM 44156

MAC 60

M.avium subsp. avium ATCC 25291

M.avium subsp. avium DSM 44156

MAC 61

M.avium subsp. avium ATCC 25291

M.avium subsp. avium DSM 44156

MAC 62

M. avium subsp. avium A TCC 2529

M.avium subsp. avium DSM 44156

MAC 63

M.avium subsp. avium ATCC 25291

M.avium subsp. avium DSM 44156

MAC 67

M.avium subsp. avium ATCC 25291

M.avium subsp. avium ATCC 25291

MAC 83

M.avium subsp. avium ATCC 25291

M.avium subsp. avium DSM 44156

M. celatum 150798*

M. celatum 16S rRNA gene

M. celatum DSM 44243

Table 3.5 showing 16S rRNA gene typing identification of Dublin isolates using
both BLAST and RIDOM online databases

• MAC analysis
The following sections will relate solely to the 66 MAC isolates that were identified
to a species level only using 16S typing from Cork (n=20) and Dublin (n=46)
respectively.
*Originally there were 71 MAC isolates; however 4 of the Dublin isolates were
reclassified by St James' Hospital as M. celatum (3), and M. shimoidei (1) when they
were received by our laboratories. One Cork isolates was identified as M. lentiflaviim
by our laboratories after 16S typing, leaving a final number of 66 MAC isolates to be
identified to a subspecies level. IS profiling and sequevar identification was carriedout on these isolates so that analysis were the main methods employed to enhance the
molecular profile of the 66 MAC isolates.
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3.3.5 Amplification of MAC DNA using specific IS elements as targets for molecular
profiling.
As stated above, all 66 isolates from both sources were subjected to IS profiling.
These strain specific primers have been designed to detect the presence of species
specific IS elements which can enhance rapid identification, and provide a more
detailed molecular profile. They can also be used to rapidly determine the virulence of
an isolate as some elements appear to be present in more virulent strains. In this study
four IS elements were chosen and included:
1.IS1245

2.

IS1311

3. IS901

4. IS900

IS245: It has been determined that virulent isolates of M avium subsp. hominissuis
generally harbour high copy numbers of the IS 1245 element, while isolates lacking in
virulence do not contain this element. Therefore, positive bands at 427bp after
amplification is an indication that a MAC isolate is a virulent M. avium subsp.
hominissuis isolate. All 66 MAC isolates were amplified using IS 1245. All isolates
with the exception of Dublin MAC 05, 41, 56, 38 (which were determined as M.
intracellulare after 16S typing) were positive for this element (See Figure 3.11 and
Table 3.6). These results indicated that 62 of the MAC isolates from Cork and Dublin
were virulent in nature and belong to the M. avium subsp. hominissuis group, a
species commonly found in humans (see section 1.2.2.).
M

N

7

1

8

10

427bp

Figure 3.11 Results for IS1245 PCR amplification for 10 representative MAC
isolates. Lane M contains molecular weight marker II, N, is the negative control.
Lanes 1 through 10 contains MAC isolates from Cork. MAC 05 02, MAC 05 03, MAC
05 06, MAC 05/13, MAC 05 11, MAC 05/18, MAC 05/16, MAC 05 20, M. chelonae
05/01{-wq),

mac

06/06.

82

IS1311: This IS element can be found in most subspecies of the MAC and the closely
related M. intracellulare and can be used as a specific element to rapidly determine if
an isolate belongs to the MAC / MAI family without the need for sequencing.
Successful amplification of this element will show a band at 608bp on an
electrophoresis gel. Again, all 66 MAC isolates were subjected to analysis. Positive
bands were seen for all 66 isolates (Figure 3.12 below), providing this study with
evidence that IS1311 is a useful tool for the rapid identification and confirmation of
MAC isolates.

M

10

1

11

12

N
608bp

Figure 3.12 Results for IS1311 PCR amplification for 12 representative MAC
isolates. Lanes 1 through 12 contain MAC isolates from Dublin. MAC I, MAC 2,
MAC 3, MAC 4, MAC 18, MAC 24, MAC 28, MAC 30, MAC 35, MAC 36, MAC 37,
MAC 11.

IS901: This IS element can be used as another indicator for virulence in an isolate,
and is generally found in M. avium subsp avium isolates that have been isolated from
birds. IS901 is generally not present in M. avium subsp. hominissuis or in M.
intercellulae. Successful amplification would produce a band at 574bp on an
electrophoresis gel. In this study none of the 66 MAC isolates were positive for this
element.

IS900: is uniquely specific for the MAP subspecies. A 577bp PCR product is an
indication of MAP. This is another element that can be used for the rapid
identification of an isolate to a subspecies level without the need for sequencing
analysis. None of the 66 isolates analysed showed positive bands for IS900, indicating
that they were not MAP.
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A summary Table (3.6) below of the 66 MAC isolates following IS profiling was
compiled to gives an overview for the results obtained;

Cork
MAC 05/02
MAC 05/03
MAC 05/06
MAC 05/09
MAC 05/11
MAC 05/13
MAC 05/16
MAC 05/18
MAC 05/20
MAC 06/02
MAC 06/03
MAC 06/05
MAC 06/06
MAC 06/08
MAC 06/16
MAC 06/18
MAC 06/19
MAC 06/20
MAC 06/23
MAC 06/26

Dublin
MACl
MAC 2
MAC 3
MAC 4
MAC 9
MAC 11
MAC 12
MAC 13
MAC 14
MAC 15
MAC 18
MAC 19
MAC 24

Summary Table of IS Elements Cork Results
IS900
IS901
IS1245

IS1311

-

+

+

-

+

+

-

+

f

-

+

+

-

+

+
+

-

+

4-

-

+

+

-

4-

+

-

+

4
+

-f

-

+

-

+
+

4-

-

+

4

-

+

+

-

+

4

-

4

4

+

-

4

4

-

Summary Table of IS Elements Dublin Results
IS900
IS901
IS1245

IS1311

-

+

4

-

+

4

-

+

4

-

+

4

-

+

4

-

+

4

-

+

4

-

+

4
4

-

+

4

-

+

4

+
+

4

-
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4

Dublin

IS900

IS901

IS1245

IS1311

MAC 25
MAC 29
MAC 28
MAC 30
MAC 35
MAC 37
MAC 21
MAC 22
MAC 23
MAC 26
MAC 32
IVIAC 38^
+

MAC 39
MAC 40

+

MAC 41^
MAC 43
MAC 44
MAC 47
MAC 49
MAC 50
MAC 56*"
MAC 60
MAC 61
MAC 62
MAC 63

■f

4

+

4

+

4-

-i

4-

+

+
4-

+

4-

+

4-

-f

+

+

-f-

MAC 65
MAC 59

4-

4

+

4-

MAC 67

+

4-

+

MAC 05^
MAC 31

+

4-

MAC 42
MAC 47

+

4-

MAC 83

+

+
+

Table 3.6 Table illustrating IS results for 66 MAC isolates examined in this study

3.3.6 hsp65 primer selection and amplification
^ Isolates were confirmed as M. intracellulare after 16S typing
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As outlined earlier hsp65 typing is extremely discriminating. The appearance of single
or multiple polymorphisms at strategic locations along the length of the hsp65 gene is
indicative of a sequevar. The same template DNA that was used for 16S rRNA gene
typing was also used for amplification of this gene. Different sets of primers were
used in this study. To confirm the efficiency of subsequent hsp sequevar analysis,
preliminary PCR was carried out using the broad range y[kChsp65 (1621 bp) primers
(Figure 3.13).

12

N

1621bp

Figure 3.13 Representative PCR results from M\Chsp65 primer amplification
for 12 representative MAC isolates samples. Lane M contains molecular weight
marker II, N is the negative control. Lanes 1 through 12 contain MAC isolates from
Dublin. MAC 28, MAC 18, MAC 13, MAC 25, MAC 37, MAC 15, MAC 11, MAC 4,
MAC 30, MAC 2, MAC 3, MAC 19.

• Sequevar Analysis
Subsequent primers were chosen in accordance with the study of sequevar analysis
carried out by Telenti et al (1993) and Turenne et al (2005) (primer sequences can be
found in section 2.3). Primers that were used specifically for sequevar analysis
included;
1. Av;765TBll/12(441bp).
2. hsp574(1059bp).

In total all 66 MAC isolates were successfully amplified using both sets of primers.
Once again PCR products were resolved on a 1.5% agarose gel electrophoresis.
Figures below show representative gels for both primer sets. Amplification of the TB
11/12 demonstrated a band at 441 bp (Figure 3.14) and amplification of hsp574
showed amplification at 1059bp (Figure 3.15).
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M

1

2

3

4 5

6 7

8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 N

441 bp

Figure 3.14 Representative results of the hsp65 (TBll/12) PCR for 25
representative MAC isolates samples. Lane M contains molecular weight marker
II, N is the negative control. Lanes I through 25 contain MAC isolates from both
Dublin and Cork. MACl, MAC 2, MAC 4, MAC 24, MAC 35, MAC 05/02, MAC

05/06, MAC 05/11, A/IAC 05/13 MAC 05 18, MAC 06 05, MAC 06,19, MAC 06/19,
MAC 06 23, MAC 06/20, MAC 11, A'fAC 13, MAC 14, MAC 15, MAC 18, MAC 19,
MAC 20, MAC 24, MAC 28, MAC 30.

M

I

9

10

11

12

13

14

N

1059bp

Figure 3.15 Results for hsp574 primer amplification for 14 representative
MAC isolates samples. Lane M contains molecular weight marker II, N is the
negative control. Lanes 1 through 14 contain MAC isolates from Dublin. MAC 28,

MAC 18, MAC 13, MAC 25, MAC 37, MAC 15, MAC 11, M. celatum 150798,
MAC 30, MAC 2, MAC 3, MAC 19, MAC 36, MAC 12.
Isolate M. celatum 150798 was originally identified as a MAC by St James' Hospital
Dublin, but was subsequently changed to M. celatum after further analysis on their
part. As indicated earlier, it was confirmed as M. celatum in this study by 16S rRNA
typing also, and was removed from the rest of this study.
Following successful amplification for products amplified by primers TBl 1/12 and
hsp574, both products were purified as before and sent for sequencing (for each
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isolate n=132). Results obtained from sequencing were then used to assign sequevars
to each MAC isolate.

3.3.9 Sequevar analysis on MAC isolates
Outline of sequevar process:
Figure (3.16) outlines the primers used for the identification of sequevar codes along
the hsp65 gene.

Sequevar analysis was carried-out in accordance with the procedure outlined by
Turenne et al

, on all 66 MAC isolates, and is based on SNP (single nucleotide

polymorphism) analysis and subsequent analysis using the DNASTAR'*^^ programme
SeqMan.

Depending on the number of SNPs detected along the PCR amplified
sequence for each isolate, a specific sequevar code (1-14) was assigned based
on the MAA104 reference sequence (Figure 2.1 materials and methods). For
example, isolates designated as sequevar code 2 had 3 SNP compared to
MAA104, while those assigned code 3 had 5 SNP. Figure (3.17) below
illustrates the section of a representative SNPs for two of the MAC isolates
examined (MAC 14 and MAC 06/03). Each of the 66 MAC isolates were
profiled accordingly, and compared to the MAA104 genome. Results for all
isolates can be seen in Table 3.7, while Table 3.8 gives the assigned sub
species for each sequevar code.

The same process was carried out for the identification of M.intracellulare
isolates, with the exception that sequences were aligned against ATCC13950
(M.intracellulare type)
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Figure 3.16 shows a representative alignment for 2 isolates (MAC 14 and MAC
06/03) sequence comparison for SNPs of MAC isolates
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Sequevar Analysis of MAC Isolates from Cork and Dublin
Cork
MAC05/02
MAC05/03
MAC05/06
MAC05/09
MAC05/11
MAC05/13
MAC05/16
MAC05/18
MAC05/20
MAC06/02
MAC06/03
MAC06/05
MAC06/06
MAC06/08
MAC06/16
MAC06/18
MAC06/19
MAC06/20
MAC06/23
MAC06/26

Sequevar
code
1
1
2
1
1
1
1
1
2
1
2
1
1
1
2
2
2
3
1
2

Dublin
MAC 1
MAC 2
MAC 3
MAC 4
MAC 9
MAC 11
MAC 12
MAC 13
MAC 14
MAC 15
MAC 18
MAC 19
MAC 24
MAC 25
MAC 26
MAC 28
MAC 30
MAC 35
MAC 37
MAC 21

Sequevar
code
1
1
1
1
1
1
2
2
2
1
1
1
1
1
1
1
2
1
1
1

Dublin
MAC 22
MAC 23
MAC 29
MAC 32
MAC 38
MAC 39
MAC 40
MAC 41
MAC 43
MAC 44
MAC 59
MAC 49
MAC 50
MAC 56
MAC 60
MAC 61
MAC 62
MAC 63
MAC 65
MAC 67

Sequevar
code
1
1
1
1
10
1
1
10
2
1
2
1
1
10
2
2
3
1
1
1

Dublin
MAC 05
MAC 31
MAC 42
MAC 47
MAC 83
MAC 36

Sequevar
code
10
1
1
1
1
1

Table 3.7 Showing Sequevar codes for each of the MAC isolates
Below is a reference table adapted from Turenne et al’^^ (Table 3.8) which assigns a
subspecies sequevar code based on the location of the SNP. Using this table, we were
able to assign a sub-species to each of the 66 MAC isolates.
Accepted subspecies
Sequevar
Code
M. avium suhsp. hommissuis
8
M. avium subsp. hominissuis
9

M. avium subsp. hominissuis
M. avium subsp. hominissuis

3

M. avium suhsp. hominissuis

10

M. intracel/ulare

4

11

M. intracellulare

5

M. avium subsp. avium
M. avium subsp. silvaticum
M. avium subsp. paratuberculosis

12

M. intracellulare

6

M. avium subsp. paratuberculosis

13

M. chimaera^

7

M. avium suhsp. hominissuis

14

M. intracellulare

Sequevar
Code
1
2

MAC Species

MAC Species

Table 3.8 Legend of strains of MAC associated with each sequevar 1-14
" Code 13 is classified as M. chimaera and is related to M.intracellulare. None of the isolates in this
study were positive for code 13.
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62 of the MAC isolates were identified as M avium subsp. hominissuis and fell within
sequevar code 1,2 or 3.
This was the first time sequevar analysis was carried out on a group of MAC isolates
in Ireland. The analysis was able to identify all MAC isolates to a sub-species level,
since 16S typing can only discriminate to a species level. 62 MAC isolates in this case
were identified as M avium subsp. hominissuis which co-incides with the results from
IS profiling IS 1245. This species is commonly isolated from humans, and since all
isolates in this study were from human patients M avium subsp. hominissuis would
have been the most likely sub-species encountered. From this analysis 72% of all
isolates were represented by sequevar code 1 (see Table 3.8) while 25% fell in code 2
and finally only 3% were represented by code 3. There was only one isolate in Cork
represented by code 3 (MAC 6/20), the patient was an elderly male and the isolate
was of respiratory origin. Unfortunately, no epidemiological data was given with the
Dublin isolates; therefore we were unable to determine the origin of the single code 3
isolate.

Since it was not possible to confirm the identity of these isolates after IS profiling, the
four of the species that were identified previously as M. mtracellulare after 16S
typing were also confirmed using sequevar analysis as code 10 (M intracellu/are);
proving sequevar analysis is a more accurate method for identification of MAC / MAI
to a sub-species level.
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Summary;
This figure outlines the identification process of the 100 NTM isolates to a species
level; and in the case, of MAC isolates, to a subspecies level (Figure 3.18);

ZN staining
DNA Extraction.

j

GITC lysis all 100 NTM
isolates.

j

Confirms the presence
of NTM.

J

16S Typing.
Identified all 100 NTM to a
species level.

Identification
of MAC sub-species

Sequevar analysis

IS profiling
Identified virulence and
sub-species of MAC
isolates.

^

Identified 66 MAC isolates
to a subspecies level.

J

Figure 3.17 Summary of identification process of clinical isolates
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3.4 ENVIRONMENTAL ANALYSIS OF NTM
3.4.1 Collection of Water Samples
All 70 water samples from the Cork area, were collected and recorded using a series
of parameters such as pH, temperature, location and weather conditions. Table 3.9
represents the relevant information for all 70 samples and can be seen below:

No

Location of
sample

Date

Initial
Temp

pH

Conditions

Source

Decontaminatioi
method

1

Lee fields

23/01/2009

5

7.26

Heavy Rain

River

NaOH

CPC

2

Lee fields

23/01/2009

5

7.28

Heavy Rain

River

NaOH

CPC

3

Lough East

23/01/2009

4

7.63

Heavy Rain

Lake

NaOH

CPC

4

Lough North

23/01/2009

4.5

7.72

Heavy Rain

Lake

NaOH

CPC

5

Lough West

23/01/2009

4

7.79

Heavy Rain

Lake

NaOH

CPC

6

Lough South

23/01/2009

4

7.76

Heavy Rain

Lake

NaOH

CPC

7

C.I.T

23/01/2009

7

8.03

Heavy Rain

River

NaOH

CPC

8

C.I.T

23/01/2009

11

8.04

Heavy Rain

Stream

NaOH

CPC

9

Glenville
Woods

24/01/2009

10

7.17

Heavy Rain

River

NaOH

CPC

10

Glashaboy'

24/01/2009

13

7.32

Heavy Rain

River

NaOH

CPC

11

Black water

25/01/2009

7.9

7.49

Heavy Rain

River

NaOH

CPC

12

Doneraile Pk

25/01/2009

10

7.72

Heavy Rain

River

NaOH

CPC

13

Milking Parlour

26/01/2009

18

6.11

Heavy Rain

Milking
Parlour

NaOH

CPC

14

House
Carrigtohill

26/01/2009

11

6.14

Heavy Rain

Tap

NaOH

CPC

15

House Lisgoold

26/01/2009

18

5.39

Heavy Rain

Tap

NaOH

CPC

16

House
Knockraha

26/01/2009

18

7.08

Heavy Rain

Tap

NaOH

CPC

*

Samples highlighted in red were identified as being positive for NTM.
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Decontamination
method

No

Location of
sample

Date

Initial
Temp

pH

Conditions

Source

17

Knockraha

26/01/2009

18

4.39

Heavy Rain

River

NaOH

CPC

18

Lisgoold

26/01/2009

18

6.96

Heavy Rain

Lake

NaOH

CPC

19

Knockraha

01/02/2009

5

6.55

Heavy Rain

Holy
Well

NaOH

CPC

20

Knockraha

01/02/2009

5

7.15

Heavy Rain

River

NaOH

CPC

21

Knockraha

01/02/2009

4

7.15

Heavy Rain

River

NaOH

CPC

22

Atlantic Pond

20/02/2009

4

7.38

Heavy Rain

Lake

NaOH

CPC

23

House
Dunmanway

20/02/2009

4

6.83

Heavy Rain

Tap

NaOH

CPC

24

House
Dunmanway

20/02/2009

5

6.47

Heavy Rain

Tap

NaOH

CPC

25

Kanturk

10/03/2009

7

6.4

Heavy Rain

River

NaOH

CPC

26

Banteer

10/03/2009

7

6.56

Heavy Rain

River

NaOH

CPC

27

Kanturk

10/03/2009

4

6.38

Heavy Rain

River

NaOH

CPC

28

Garrettstown

28/03/2009

10

7.1

Dry

Outside
Tap

NaOH

CPC

29

Garrettstown

28/03/2009

10

7.88

Dry

River

NaOH

CPC

30

Farren woods

28/03/2009

10

7.22

Dry

Deep
Lake

NaOH

CPC

31

Farren woods

28/03/2009

10

7.1

Dry

Stream

NaOH

CPC

32

Farren woods

28/03/2009

10

7.44

Dry

Lake

NaOH

CPC

33

Farren woods

28/03/2009

10

7.34

Dry

Lake

NaOH

CPC

34

C.l.T

28/03/2009

7

7.74

Dry

Tap

NaOH

CPC

35

House Mallow

28/03/2009

7

6.54

Dry

Tap

NaOH

CPC

36

Mallow

20/04/2009

7

6.73

Dry

Stream

NaOH

CPC

37

Walkway

19/05/2009

11

7.46

Heavy Rain

Stream

NaOH

CPC

38

Bride

19/05/2009

12

7.44

Heavy Rain

Stream

NaOH

CPC
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No
39

Location of
sample
House
Blackrock

Date

Initial
Temp

pH

Conditions

Source

Decontamination
method

20/04/2009

10

7.12

Dry

Tap

NaOH

CPC

NaOH

CPC

40

House
Carrignavar

20/04/2009

7

6.66

Dry

Tap

41

Owenboy

19/05/2009

10

7.31

Heavy
showers

River

42

Ballygarvan

19/05/2009

15

7.44

Heavy
showers

Stream

NaOH

CPC

43

Owenboy

19/05/2009

10

6.92

Heavy
showers

River

NaOH

CPC

44

Crookstown

19/05/2009

12

7.35

Heavy
showers

River

NaOH

CPC

45

Bathairin an
Atha

19/05/2009

14

7.34

Heavy
showers

Stream

NaOH

CPC

46

Owenboy

19/05/2009

12

7.59

Heavy
showers

River

NaOH

CPC

47

Sweeny Quay

19/05/2009

10

7.21

Heavy
showers

River

NaOH

CPC

48

Carrigtohill

19/05/2009

12

7.5

Heavy
showers

River

NaOH

CPC

49

Owenacurra

19/05/2009

10

7.78

Heavy
showers

River

NaOH

CPC

50

Bandon

19/05/2009

12

7.16

River

NaOH

CPC

51

Carrighyde

19/05/2009

10

7.3

Lake

NaOH

CPC

52

Bandon

19/05/2009

11

7.29

Heavy
showers

Lake

NaOH

CPC

53

Carrigadrohid

19/05/2009

14

7.29

Heavy
showers

Lake

NaOH

CPC

54

House, Spur Hill

19/05/2009

12

5.66

Heavy
showers

Tap

NaOH

CPC

55

Mill Pond

19/05/2009

10

7.33

Heavy
showers

Pond

NaOH

CPC

56

OwennacuiTa

19/05/2009

12

7.34

Dry

River

NaOH

CPC

57

Lough Aderry

28/05/2009

11

8.36

Dry

Lake

NaOH

CPC

58

Kiltha

28/05/2009

9

7.78

Dry

River

NaOH

CPC

59

Dissour

28/05/2009

14

7.46

Dry

River

NaOH

CPC

60

Blackwater

28/05/2009

12

7.43

Dry

River

NaOH

CPC

61

Shanowen

28/05/2009

10

7.17

Dry

River

NaOH

CPC
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Heavy
showers
Heavy
showers

NaOH

Decontamination
method

No

Location of
sample

Date

Initial
Temp

pH

Conditions

Source

62

Durrus

29/05/2009

12

6.8

Dry

River

NaOH

CPC

63

Owennashing

30/05/2009

10

6.77

Dry

River

NaOH

CPC

64

Brewery

31/05/2009

14

6.37

Dry

River

NaOH

CPC

65

Riverstick

01/06/2009

10

6.94

Dry

Stream

NaOH

CPC

66

Bandon

02/06/2009

10

7.05

Dry

River

NaOH

CPC

67

Garranes

03/06/2009

12

7.12

Dry

Lake

NaOH

CPC

68

Brave heart

04/06/2009

10

7.2

Dry

Stream

NaOH

CPC

69

River Dirty

05/06/2009

12

7.86

Dry

River

NaOH

CPC

70

Ganyvoe

06/06/2009

9

7.18

Dry

River

NaOH

CPC

Table 3.9 Information relating to the collection and recording of water sample
data throughout the environmental study
The primary objective was to isolate mycobacteria from as many samples as possible.
The difficulty in this is the necessity to de-contaminate the samples in order to
eliminate contaminating microbes. Consequently, initial experiments were carried out
to optimise this decontaminationprocedure.

3.4.2 Colony Counts and Spiking of Water.
Spiking experiments were used to help determine which of the decontamination
methods would be more useful in this study, and more likely to inhibit other
contaminants in the water. For this purpose M. smegmatis was used (as it is a
relatively-fast grower). The counts to determine the initial inoculum for each of the
samples were carried-out in triplicate, and incubated for 2 - 3 days prior to
enumeration. Post decontaminationsamples were incubated considerably longer. For
example, samples de-contaminated with NaOH showed growth after 4-5 days; while
samples decontaminated with CPC took on average 6 days to grow. This was
undoubtedly due to the toxic stress of de-contaminant (Table 3.11 illustrates the
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results and the percentage loss for these counts), with the optimised parameters
highlighted in red for each method (Table 3.10(a) and (b) below).

(a)
Concentration of CPC
Time
5mm
lOmin
15min
20min
25min

0.10%

0.05%

0.03%

0.001%

NG^

NG

NG

Growth*^

NG

NG

NG

NG

NG

NG

NG

NG

NG

NG

NG

NG

NG

NG

NG

NG

(b)
Time

5min
lOmin
15min
20min
25min

Concentration of NaOH
1.0% 1 0.60%
0.30%
NG
TNTC
C‘
NG
Growth
c
NG
NG
c
NG
NG
c
NG
NG
c

0.10%

c
c
c
c
c

Table 3.10 Optimisation results for decontaminationwith CPC (a) and NaOH (b)
for tap water
Results for spiking of water samples
Decontaminant
CPC 0.001%
concentration, 5
minutes
NaOH 0.6%
concentration for 10
minutes

Average result pre
decontamination

Average result post
decontamination

% loss

3.7 X lO^cfu/ml

2.4x 10^ cfu/ml

93.52%

4.Ox 10^ cfu/ml

3.3x 10^ cfu/ml

91.75%

Table 3.11 showing results for spiking of water samples
'^NG indicated de-contaminant was too toxic and no growth was observe.
^Growth indicated that countable colonies were seen for these parameters.
‘

Contamination indicated that the decontaminant wasn't strong enough to kill contaminating

microbes in spiked water.
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From these results it was decided that these were the most suitable decontamination
methods to use on the collected water samples.

3.4.3 Cultivation of environmental isolates
All 70 water samples were subjected to decontamination by both optimised methods
and were incubated at 3>fC. Plates were examined on a twice weekly basis until
colonies were formed.

Some plates which were decontaminated with NaOH showed growth after 5-7 days;
however, these colonies were contaminants as determined by simple gram stain
analysis. Approximately 20% which were decontaminated by NaOH, showed signs of
mould growth. These plates were mainly from river sources.

Some plates decontaminated with CPC began to show growth after 2 - 3 weeks, and
overgrowth by other bacteria was a lot less prevalent on these plates. Suspect
mycobacterial colonies were removed for DNA extraction and streaked onto fresh
agar for further analysis. Colonies that took over 4 days to culture were examined by
ZN staining and sent for sequencing following PCR analysis (16S rRNA gene).

DNA was extracted from all suspect colonies, using GITC lysis as previously
described. Results can be seen in Figure 3.19. Following 16S PCR and gel analysis,
the samples were sent for sequencing to MWG.

M

C

1

3

4

5

6

N

1059bp

Figure 3.19 Results for 16S rRNA gene amplification of water samples. Lane M
contains molecular weight marker II, N is the negative control and C is the positive
control. Lanes 1-6 contain suspect colonies from water samples. Water 27, Water 28,
Water 29, Water 30 Water 31, Water 32.
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3.4.4. Sequencing and identification of Environmental Isolates

Sequences from all positive were then submitted to RIDOM and BLAST similarity
search databases. In total 5 isolates were proven positive using 16S analyses. Table
3.12 below lists the positive samples, their source and what mycobacteria were
identified.

Sample
No
10
12

31
33

Source

Species Identified

Pathogenesis

Growth
rate

Glashaboy River
Doneraile Park
Lake
Farren woods
stream
Farren woods Lake

M. tokaiense'^

Not known

RGM

M. murale^

Not known

RGM

M. alvef

Non pathogenic

RGM

M. alvei

Non pathogenic
Non pathogenic.
Mycobacterial
contaminant

RGM

Owennacurra
River

56

M. gordonae^

SGM

Table 3.12 Positive mycobacterial samples obtained from water
The five positives that were identified as mycobacteria took on average 6-8 weeks to
form colonies, even though once identified they were shown to be RGM. Once these
colonies were sub-cultured growth occurred within 7 days, which demonstrated
mycobacterial growth was inhibited by the initial toxic decontamination.

Two of the positive samples. Water 31 and Water 33, were collected on the same day
and were from a similar location (Farren woods). One was a sample from a stream
(31), while the other was sampled from the lake (33). pH readings for both samples
were approximately 7.0. One of the samples (Water 56) was identified as M
gordonae which is commonly found in water and is considered non- pathogenic, but

has also been isolated from humans as an opportunistic pathogen. Water samples 10
This species was originally isolated from soil.
"

°

First isolatedfrom water-damaged indoor building material, Finland.
First isolatedfrom water samples, from soil and human sputum samples, Spain

^ Can be isolatedfrom tap water, soil. Casual resident in human sputum and gastric lavage
specimens.
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and 12 were both collected from rivers, water sample 10 was identified as M
tokaiense, while water 12 was identified as M murale. These two species are closely
related on the phylogentic tree (see Figure 1.3 page 15).

Out of the 70 water samples collected 7% were positive for NTM; all 5 original
samples had a pH value within the range of 7.1 and 7.7. The highest pH recorded in
this study was 8.4 with the lowest being 4.39, indicating that the NTM in Cork may
prefer environments around neutral pH. 40% of the positive samples were from rivers
and 40% were from lakes; the final 20% was sourced from a stream. None of the tapwater samples were positive for NTM. 60% of the positive isolates were collected
during dry weather, while the other 40% were collected after heavy rain. With the
exception of Samples 31 and 33 the other 3 isolates were not relatively close in
location, as can be seen on the map provided in the appendix section (pgl 15). Finally,
all of the positive isolates were decontaminated using CPC. NaOH decontamination
produced no positives in this study.

3.4.5 DNA extraction from water culture independent.
An attempt was made to directly extract mycobacterial DNA from the water samples.
Small volumes of concentrated water were spun down, and pellets were lysed by the
GITC method. PCR was performed on all isolated DNA using 16S universal primers
(the same primers used for typing); products were then run on a 1.5% agarose gel and
visualised under UV light. All samples analysed using this method failed to show
bands on agarose gel, and where therefore deemed to be negative; a sample gel can be
seen in Figure 3.20.
MN1

234567C

1059pb

Figure 3.20 Results for 16S rRNA gene amplification of water samples DNA
direct from water. Lane M contains molecular weight marker II, N is the negative
control and C is the positive control. Lanes 1-7 contain suspect colonies from water
samples. Water 41, Water 43, Water 56, Water 50, Water 53, Water 47, Water 49.
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In summary, this was the first study of its kind to be performed in Southern Ireland.
Five isolates were successfully cultivated and identified using the processes outlined
in the above sections.
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Chapter IV
Discussion
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Discussion:
The incidence of individual infections and outbreaks associated with NTM has risen
dramatically over the past decade establishing these organisms as significant human
pathogens’^. Traditionally, the identification of mycobacteria to the species level has relied
upon biochemical tests, which can take from three to six weeks to complete’^’ ’

This study

describes the application of several molecular methods for the rapid identification of NTM
isolates, from two hospitals in southern Ireland, to a species and sub-species level. Isolates
were previously identified to a species level by traditional methods, utilised in both hospital
laboratories.
This was the first epidemiological study of its kind to be performed on a set of Irish
cn

NTM isolates since 2003 . The epidemiological study was based on patient information
gathered from Cork isolates, and used to compare the incidence of NTM infections in
Southern Ireland, with previous studies by’^’

^.In terms of incidence Figure 3.1 shows that

on average only 2. INTM were isolated each month. This is an increase since Kennedy et al's
study which showed on average 1.25 NTM isolates were recovered each month. In total 50
isolates were extracted over the 2 years (2005-2007) of this study, while Kennedy collected
175 NTM isolates over the 14 years of their study (1987-2000). On average 13.5 NTM
isolates were obtained each year during Kennedy's study, while 25 NTM isolates on average
were collected each year during this study, indicating that the incidence or detection of NTM
is on the increase in Ireland. Another recent study carried out by van Ingen et al

showed

the incidence of NTM infection from the Nijmegen-Arnhem region in the Netherlands. The
study lasted 6 years and involved 232 NTM isolates recovered from 4 hospitals, which
equates to 3.2 NTM isolates a month. There is a slight difference between the Irish and the
Dutch studies but may be due to a higher population in the Nijmegen-Arnhem region
(728,500) compared to Cork (380,000).
When the profile of patients was examined, 78% identified in this study with NTM
infections were over the age of 50, while 28% of these alone were between 71-80 years. This
co-incides with other studies, which clearly show that older people are more susceptible 57 ’ 131
^.

In our study it was proven that more men suffered from mycobacterial infection (68%),

while only 32% were isolated from women. This may be due to lifestyle choices of many
older men which can generally increase their risk factors for NTM infection, especially with
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strains such as MAC and M kansasii^'^. Interestingly when MAC isolates were examined in
the absence of the NTM the gender ratio were seen to be 50 / 50. Since NTM infections are
more commonly associated with the lung, it wasn't surprising that 85% of NTM isolates were
found to be of respiratory origin. This was similar to van Ingen^'^’, who showed in their study
that 91% of isolates were also of respiratory origin. Other sites of infection from the Cork
isolates included abscesses, cysts, bursae, and blood orbitals. Some of the patients showed
repeat infection; specifically two patients had recurring infection during the collection of
respiratory isolates donated to this study. Patient (a) had M abscessus isolated twice over a 2
month period, while patient (b) had M. chelonae isolated twice over a 4 week period (Table
3.1). The recurrence of the strain in each case may be due to ineffective drug regime, or the
patient may be in prolonged contact with an environmental source of NTM. Alternatively
these patients may have had a compromised immune system rendering them more susceptible
to infection.
Over the last 7 years 259 NTM isolates were recovered from patients at St James'
Hospital.Of these 86 (33%) were MAC making this sub-group the most commonly
encountered NTM. Fifty of these most recent isolates (2005, 2006, and 2007) were donated to
this study. Cork showed a similar trend, that over the 2 year collection period of this study.
2 lof the fifty isolates (44%) were identified as MAC. Other epidemiological studies carried
out’^’

concur with these results including^^ which shows that 71% (n=45) of all isolates

collected over the course of a one year study were MAC. These studies confirm that MAC is
the most commonly isolated NTM from humans in developed countries.
Since mycobacteria are often difficult to identify in clinical samples, identification to
a species level is of paramount importance to ensure adequate patient care, as treatment
regimes may differ depending on species type identified^^’At present, the diagnosis of
NTM disease relies on multiple assays that are generally poor in accuracy and require long
periods of laboratory tests''^^. Molecular analysis of mycobacterial isolates is becoming the
preferred method of choice for scientists in some laboratories

This is evident based on our

own experience in this study, as St James' Hospital recently introduced the HAIN test as part
of their mycobacterial testing programme.
It is well accepted that the 16S rRNA gene has become the gold standard for the
molecular characterisation of mycobacteria^*’The reason for this is the 16S rRNA gene
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is universally present in bacteria, and has both highly conserved and more variable domains^’
This makes it an ideal target for the identification of mycobacteria to a species level, mark
evolutionary distance and assess the relatedness of the organism'^.
16S rRNA gene typing was the initial and primary molecular tool used in this study
for the identification of all 100 mycobacteria isolates to a species level. The protocol used in
this study was based on an established method for amplification of the 16S rRNA gene^^,
following optimisation experiments (Table 5.4). It is a rapid method for identification of
mycobacteria as it can be applied to a single colony and results can be achieved within
hours

Based on our results it was determined that 6% of the Cork bank of strains were

different from the original C.U.H identification, with three isolates in particular displaying
discordant results. M kansasii 05/22 and MAC 06/13 were both identified as M. lentiflavum,
while M. xenopi 06/04 was identified as M nonchromogenicum (see Table 3.4). The
phylogentic relationship for each species can be seen in Figure 3.10, which shows that M.
lentiflavum is not related to either M. kansasii or MAC, while M. nonchromogenicum is more
related to M terrae than M. xenopi. This was a significant finding, since treatment regimes
are species specific for many strains of mycobacteria. All hospitals should consider the
advantages of molecular typing of NTM isolates, for rapid and accurate identification, which
should lead to faster patient recovery times.
It was possible to identify 100% of isolates to a species level using 16S rRNA typing
in conjunction with the online databases BLAST and RIDOM

. Both databases were 100%

concordant for each of the isolates which strengthens our results, although neither database
was able to discriminate between the closely related sub-species of MAC. Consequently other
molecular methods were developed and employed for the identification of these sub-species.
IS elements are useful molecular tools for determining subspecies of NTM, as many
IS sequences are species specific

’ . IS elements, in some instances facilitate the

identification of an NTM isolate to a subspecies level without sequencing. The host range of
the mycobacteria can also be determined from IS profiling (e g. from avium, porcine, bovine
or human sources)"^^’This study looked at four IS elements, IS 1245^, IS1311^, IS901^ and
IS900^^. Some were species specific and were rapidly able to determine the identity of a
subspecies of MAC (e.g. IS900 and IS 1901). Other elements indicate the virulence potential
of an isolate, which is important for molecular epidemiological studies (e.g. IS 1245).
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It was quickly determined from this study that none of the isolates were of MAP
origin since they were all IS900 negative. It would have been unusual if any of the isolates
were identified as MAP, since this sub-species is more commonly associated with enteric
disease in humans (none of the isolates were isolated from enteric sources)^^. It is thought
that the element IS901 is present in high copy numbers in M. avium subsp avium, which can
be associated with human infection but since none of our 66 isolates were positive for this
element, initial results indicated that none of the MAC isolates belonged to this sub-group.
IS1311 is common in all MAC as it is species specific, 100% of the MAC isolates in this
study were positive using this target. The most valuable IS element used in this study, was
IS 1245 as it was able to identify 94% of the MAC isolates as virulent

suhsp.

hominissuis. Interestingly this sub group is commonly associated with MAC infections in
humans according to other reports^. Furthermore it has been reported'*^ that M. intracellulare
does not harbour IS 1245. The 4 isolates that were identified as M intracellulare in our study
after 16S typing, could not be identified using this specific IS element (as expected),
therefore it was necessary to carry out further analysis on these isolates to produce a more
detailed molecular profile. In the case of MAC, hsp65 sequevar typing remains one of the
most definitive means of classifying strains, and was used in this study for all 66 MAC
isolates
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As mentioned above the hsp65 gene, (which is also present in all mycobacteria), is
often considered more variable than the 16s rRNA gene sequence and therefore more useful
for the identification of genetically related species such as MAC

. It has also become a

routine method for taxonomical studies*^^’^"^’^^ due to the polymorphisms which are able to
help differentiate closely related species of mycobacteria. This study employed sequevar
analysis of the hsp65 gene for the identification of MAC isolates to a sub-species level
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After PCR analysis and sequencing, sequences were aligned against the MAA104 reference
genome to quickly identify the SNP in each isolate and to assign a code. In total, 68% of the
MAC isolates were represented by code 1, while 23% were identified as code 2. 3% were
confirmed as code 3 and finally 6% were identified as code 10. As can be seen from Table
3.8 codes 1,2 and 3 are classified as M avium subsp hominissuis

which matches the earlier

results obtained from IS profiling where these MAC isolates were recorded as M avium
subsp hominissuis. The final 4 isolates (code 10) which were identified as M intracellulare
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following 16S typing were confirmed as this species after sequevar analysis, again indicating
the utility of employing multiple typing strategies.
Since M avium subsp homimssuis is commonly isolated from humans, it was of little
surprise therefore that the majority of MAC isolates were confirmed as this species after
sequevar analysis, considering that all 66 strains were initially recovered from human sources
Alvarez et al used both sequevar coding and IS 1245 profiling of clinical and environmental
isolates from a Spanish Hospital located near Madrid. In this study positive MAC isolates
that were identified as M avium subsp hominissuis were IS 1245 positive and mainly
represented by sequevar code 1. Two other isolates that were IS1245 positive were identified
as code 2 and 3 after sequevar analysis. Other studies by Ichikawa et al^’

analysed 114

clinical MAC isolates, of which 100% were identified as M. avium subsp hominissuis after
sequence analysis of the hsp65 gene. It was also shown that 96% of the isolates were also
IS 1245 positive. This relates with our study that illustrates that M. avium subsp hominissuis
is currently the most common MAC species extracted from humans. A final study by
Johansen et al^*^^^^ analysed 83 MAC isolates collected from both Human Swine and avian
sources. Twenty-six of the human isolates were analysed using hsp65 sequevar typing and
their findings showed that 34% were represented by sequevar code 1, 12% by code two and
finally 54% by code 3. All human isolates were of M. avium subsp hominissuis origin; this
study however showed code 3 was the most predominant.
This was the first molecular study of its kind to identify closely related species of
NTM in Ireland. Like 16S typing, IS profiling and hsp65 analysis can be performed quickly
in clinical labs and can produce rapid results without the need for biochemical analysis. Even
though the patient prophylactic regime is similar for all MAC isolates, specific sub-species
may be more resistant to certain drugs assigned for patient treatment, therefore it is beneficial
to record the identity of the MAC sub-species in order to expedite treatment. hsp65 can also
be used to identify other closely related species of mycobacteria apart from MAC*^’
providing evidence of this gene's reliability to identify mycobacteria to a species and sub
species level. However due to the small number of these species in our bank it was felt
unnecessary to do so.
After identifying all 100 clinical isolates to a species and subspecies level, a
secondary study was performed to determine the occurrence of NTM from natural water
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sources. Again this was the first study of its kind to be performed in Southern Ireland.
Environmental mycobacteria are commonly found in water, soil and dust

and are generally

considered saprophytic^^^; however some are potentially pathogenic for humans, and are
considered opportunistic pathogens" ’ . Mycobacteria can generally survive in many hostile
environments such as high pH, or temperatures extremes ’

, and due to their ability to form

biofilms can make them resistant to many environmental toxins^^^.
Several options had to be taken into consideration before this study was undertaken,
such as the length of the study, the number of samples required, source of each water sample,
and the feasibility of multiple sampling. In the end it was finally decided that a bank of 70
water samples from a variety of sources would be collected to determine the prevalence of
NTM from environmental sources, in the greater Cork region.
Before water samples were processed, two decontamination methods were chosen
after extensive reviews of previous studies. Optimisation of each method was also carried out
to determine if the recommended times and concentration of decontaminants were suitable
for this study. The first method taken from Eun-sook et al^^ was one of the more recent
methods to be utilised and required lOOOmls of sample. It used both filtration and CPC, to
concentrate and decontaminate the water samples. The second method used the procedure
outlined by Bland et al which sampled 50mls of water from each sample, and used
centrifugation and NaOH as a decontaminant.
Many of the higher concentrations were too toxic for the mycobacteria and killed off
all bacteria at long exposure times (Table 3.10 (a) and (b)). For shorter exposure times many
of the lower concentrations showed contaminating growth indicating that these may not
suffice in killing off other environmental contaminants. It was finally determined that
decontamination with 0.001% CPC for 5 minutes would kill exogenous contaminants but
would allow for the growth of mycobacteria, and in the case of NaOH decontamination
would be performed using 0.6% NaOH for 10 minutes.
During optimisation we were able to determine the average percentage recovery for
each method, 6.48 % recovery was seen after decontamination with CPC, while NaOH had
an average recovery of 8.25%. Even though recovery results were low, they were necessary
to ensure that other contaminants in the water would be killed off during the process. An
interesting observation made during the optimisation process showed that the same
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mycobacteria used in the spiking experiments grew faster than those recovered post
decontamination. This was undoubtedly due to the toxic stress of the de-contaminant but
needed to be taken into consideration, as even if mycobacteria were present in a water
sample, the stress of decontamination may cause the growth rate of the isolate to be slowed
down considerably. Consequently all water samples were incubated for at least 8 weeks. The
positive isolates that were identified during this study were exclusively from samples
decontaminated with CPC which were incubated for at least 6 weeks. No isolates were
recovered using NaOH even from the same water samples, indicating that the
decontamination may have been too harsh or the volume used was too small. Another
advantage of CPC was less evidence of environmental contamination that could inhibit the
growth of mycobacteria.
A simple study was also carried out to determine if plating samples on Middlebrook
agar plates or slopes would yield higher results. Since the incubation period for this study was
6+ weeks it was found that the agar plates had a tendency to dry out in the incubators and
were more susceptible to contamination from other sources even after the plates were sealed
with parafilm. The slopes were more durable as they didn’t dry out and avoided
contamination from varying sources; also all 5 positive isolates were from colonies removed
from slopes indicating that slopes are a more viable method for cultivating NTM from
environmental sources.
As mentioned, in total 5 isolates (7%) were successfully cultivated and identified
using 16S typing. Two of the isolates were collected on the same day from a similar location;
one was taken from a river while the other was taken from a lake in Farran Woods. Both were
identified as M alvei which is an RGM commonly found in soil and water, and is nonpathogenic"^. It has been isolated from sputum samples in Spain and is considered a
mycobacterial contaminant but is rarely isolated from clinical sources. Samples 10
(Glashaboy) and 12 (Doneraile park) were also positive for NTM. Sample 10 was identified
as M tokaiense, an isolate commonly found in soil and water, while sample 12 was identified
as M. murale a species also commonly found in water. Both of these species are closely
related when compared phylogenetically (see Table 3.4) although the virulence potential of
these species has not yet been defined’^^ Finally sample 56 (Owennacurra river) was positive
for M gordonae, an isolate that has been extracted from environmental and human sources.
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This was the only NTM extracted that is commonly identified from clinical isolates, albeit as
an opportunistic pathogen mainly in immunocompromised individuals.
Even though pH levels varied between 4 39 and 8.4 all of the positive isolates were
recovered from samples between a pH of 7.1 and 7.3. It was determined that 40% of the
positive samples were from rivers and 40% were from lakes the final 20% was sourced from
a stream. Unsurprisingly none of the tap water samples were positive for NTM which may be
due to the treatment and chlorination of water. 47% of the water samples were obtained from
rivers as it was thought that river samples may have been more inclined to contain
mycobacteria^. Only 20% of the water samples were taken from lakes, which makes it
surprising that the same number of positives were isolated from lakes as from rivers. Since
60% of the positive isolates were collected during dry weather, it indicates that weather does
not play a significant role in the appearance of NTM in the environment.
Other studies such as Eun- Sook et al isolated 158 isolates of mycobacteria
consisting of several different species, from the Han River, surface water and tap water in
Korea using CPC as their decontaminant. This study took place over 13 months and in total
84 tap and river samples were collected (12 samples each month-6 river and 6 tap). The high
recovery rate of mycobacteria may be due to the poor water quality of the Han River.
Elsewhere Santos et al'^^ isolated two species {Mycobacterium parascrofulaceum and M.
xenopi) from hot-springs at a temperature of 58”C and a pH of 3.0, following an analysis of
18 samples collected in October (2005) and June (2006). These studies when taken with our
results indicate that mycobacteria are ubiquitous in the environment and may be a reservoir
for human infection.
An attempt was made during this study to directly extract mycobacterial DNA from
the concentrated water samples. None of the water samples were positive for mycobacteria
after 16S PCR, indicating that mycobacteria may be present below the threshold sensitivity of
the assay. To be able to determine the presence of mycobacteria directly from environmental
sources would allow for rapid identification of the bacteria, since cultivation and propagation
of mycobacteria can take several weeks, months or even years to complete. In this study it
was apparent that more optimisation of this method is required. However if implemented
correctly it would allow for new species to be identified, and to evaluate the zoonotic
potential of waterborne mycobacteria.
110

Mycobacteria represent some of the most difficult and intractable microorganisms in
nature. Yet their potential to cause disease is unmatched. As NTM are becoming more
prevalent in both clinical and environmental settings, it is necessary to continue monitoring
these bacteria to observe trends of infection, incidence rates and distribution in the
environment. This study raised questions about the reliability of testing NTM isolates by
biochemical analysis in hospital laboratories, and out lined a simple rapid molecular
procedure that would enable mycobacteria to be identified to a species level. It also
implemented techniques to identify closely related species of mycobacteria such as MAC to a
sub species level. Finally, it looked at the prevalence of NTM in the environment in a large
catchment area and used optimised techniques to isolates mycobacteria species from water.

Ill

Conclusion:
Each of the objectives that were outlined in (pg 41) were completed over the course of this
study
•

Successful cultivation and stocking of all 100 isolates donated by both the C.U.H. and
St James’ Hospital was performed. From these isolates a clinical bank was compiled
that now consists of 14 species of mycobacteria from clinical sources. Strains of
mycobacteria are available for use in future mycobacterial studies.

•

Epidemiological analysis on a small number of Cork isolates was performed and
findings were similar to other studies carried out elsewhere. In brief men are more
susceptible (62%) to NTM infection compared to women (38%), the most common
isolated strain was MAC (66%) and the most common site of infection was
respiratory (78%).

•

It was determined that 16S rRNA sequencing of NTM, is a fast and accurate approach
to identifying isolates to a species level. 16S rRNA analysis was able to correctly
identify all 100 isolates to a species level. There was a 6% difference between
molecular analysis and biochemical analysis, giving rise to the question of reliability
of the biochemical methods used by hospitals. Also biochemical analysis of isolates is
cumbersome and time consuming with identification of isolates taking up to 3 weeks
after initial cultivation.

•

Both sequencing databases BLAST and RIDOM provided identical results for each of
the 100 isolates examined and can be used for the identification of NTM to a species
level.

•

Identification of MAC isolates to a subspecies level was successfully carried out using
two molecular methods- IS profiling which identified 94% of MAC isolates as
virulent M. avium subsp hominissuis, and hsp65 sequevar analysis which identified all
66 MAC isolates to a subspecies level with the use of sequevar codes. Both methods
are rapid and assist in the identification of closely related species of NTM to a
subspecies level.
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Optimisation of decontamination methods was performed to ensure NTM growth after
decontamination of the sample.
In total 5 new isolates were cultured and identified using 16S rRNA typing, which
adds to the diversity of the laboratory collection.
Future studies:
Continued surveillance of NTM infection in Irish hospitals is necessary to detect
increases in incidence and determine changes in trends. This study built an
epidemiological profile from one hospital in southern Ireland, but should be extended
to all major hospitals to determine the incidence of NTM infections nationally, as this
would significantly contribute to our understanding of NTM infections and
transmission.
16S typing could be enhanced by developing 16S primers that are able to identify
closely related species of NTM. Real-time PCR could also be used to develop melting
curve profiles for clinically important strains of mycobacteria based on polymorphic
differences. This could then be used to rapidly identify mycobacterial species without
the need for sequencing analysis.
This study collected 70 water samples from a variety of sources, and each sample was
only collected once. A continual surveillance study over a 6 - 12 month period with a
smaller number of samples from a single source may yield higher results. It would
also be possible to establish trends such as seasonality, weather, pollution, pH, and
temperature if a more extensive study was performed this way. Larger water volumes
should also be collected to ensure adequate distribution of the water sample, since
NTM in the environment is present in such low concentrations.
Further optimisation of decontamination methods may also yield higher results since
contamination was seen in a large number of samples decontaminated by NaOH.
IS elements and species specific primers could be used to further enhance the
identification of mycobacteria from water samples.
A larger bank of environmental isolates could be generated, so that the zoonotic
potential of NTM could be determined.
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